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Abstract 
Biocatalytic processes have been emerging as potential replacements of traditional chemical synthesis in many industrial relevant production processes. However the implementation of new biocatalytic processes can be a very challenging procedure which requires both biocatalyst and process screening and characterization for economic evaluation before scale-up. Microstructured devices have been used as screening tools that allow paradigm changes in process development by shortening process development times through modularity and intensification. Customized reactor designs and process configurations by integrating different modules can be developed at microscale. Such configurations enable effective screening and rapid process development of biocatalytic reactions assuring economic viability and shorter time to market for pharmaceutical products. Thus the work presented in this thesis is based on the application of microstructured devices for screening and characterization of process options in biocatalytic processes.  The thesis focuses on interesting case studies like the asymmetric synthesis of chiral amines using ω-transaminases and synthesis of an industrially relevant imine product using monoamine oxidase. The first part of the thesis is focused on the development of novel reactor configurations for biocatalysis. A combination of microreactors and computational fluid dynamics (CFD) has been found to contribute significantly towards the understanding of diffusional properties of the substrate and the product. Such knowledge is subsequently applied to design customized reactor configurations. It has been demonstrated that this knowledge can be crucial for the choice and design of reactors. The second part focuses on developing µ-scale modules for rapid screening and integrating process units. The increase in productivity is evaluated through process metrics. A case study demonstrates the applicability of using a micro-scale packed bed column for screening synthetic resins for in-situ product removal. CFD simulations were performed to guide the design of a packed column for efficient operation. Further case studies demonstrate the development of modular set-ups with integrated processes at micro-scale to address process limitations which were determined by initial experiments at lab scale. The degree of integration of functionalities requires process optimization. Thus optimization studies were also performed by varying operational parameters. From an academic point of view, a general methodology is desired and thus a systematic screening methodology is proposed that relies on microstructured devices during process development. The methodology can be applied to other biocatalytic reactions with some limitations.  
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Résumé på dansk 
Processer baseret på biokatalyse kan i mange tilfælde være et attraktivt alternativ til traditionel kemisksyntese til produktion af mange industrielt relevante produkter. I de fleste tilfælde er det dog meget udfordrende at implementere nye biokatalytiske processer. Det er for eksempel meget tidskrævende at screene mange biokatalysatorer og forskellige proceskonfigurationer, samt karakterisere processen for at vurdere den økonomiske suverænintet, inden opskalering af processen foretages. Brugen af mikro-strukturerede moduler som et screeningværktøj, vil potentielt give et paradigmeskift i hvordan processer udvikles ved at forkorte udviklingstiden gennem brugen af standard moduler til procesudviklingen og procesintensivering. Ydermere, er det relativt nemt at lave brugerdefinerede mikro-strukturerede reaktor moduler og proceskonfigurationer til specielle applikationer. Alle disse features vil muliggøre effektiv screening og hurtig procesudvikling af biokatalytiske processer, der i sidste ende vil opfylde økonomiske restriktioner og derved forkorte tiden til markedet. Arbejdet præsenteret i denne afhandling er baseret på brugen af mikro-strukturerede moduler til screening og karakterisering af procesmuligheder i biokatalytiske processer. Med specielt fokus på to interessante casestudies. Første casestudy er asymmetrisksyntese af chirale 
aminer ved brug af ω-transaminaser og det andet casestudy omhandler syntese af industrielt relevante iminer ved brug af monoaminoxidase.  Den første del af denne afhandling fokuserer på udvikling af nye reaktorkonfigurationer til at styre de biokatalytiske processer der er i fokus. Kombineret brug af mikro-reaktorer og Computational Fluid Dynamics (CFD) har vist sig at bidrage væsentligt til forståelsen af diffusionsmæssige egenskaber af substrater og produkter. Denne viden kan efterfølgende anvendes til at designe optimale reaktorkonfigurationer. Det er blevet påvist, at denne viden kan være afgørende for valg og design af reaktorer. Anden del fokuserer på at udvikle mikro-skala moduler til hurtig screening og integrering af enheds operationer til at intensivere processer, forbedringer vurderes ved at analysere procesproduktiviteten. Et eksempel demonstrerer anvendeligheden mikro-systemer, ved at anvende en mikro-packed bed – kolonne til at screene resiner for deres anvendelighed til in-situ produkt fjernelse. CFD simuleringer blev benyttet til at designe et effektivt kolonne design. Yderligere eksempler fokuserede på at demonstrere udviklingen og optimering af modul baserede forsøgsopstillinger med integreret separations processer i micro-skala for at overkomme procesbegrænsninger, som tidligere er blevet identificeret i laboratoriet.  Fra et akademisksynspunkt er det ønsket at opnå en generel procesudviklingsmetode. Der er derfor foreslået en systematisk screenings metode for brugen af micro-systemer i denne afhandling. Den foreslåede metode er generelt anvendelig, med få undtagelser.  
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Abbreviations 
ABREVIATION DESCRIPTION 8S 8 stream reactor ACE Acetone APH Acetophenone API Active pharmaceutical ingredient ATP Adenosine triphosphate ATR Agitated tube reactor BA Benzyl acetone BV Bed volume CFD Computational fluid dynamics CFE Cell free extract CNC Computer numeric control COC Cyclic olefin copolymer CSTR Continuous stirred tank reactor CTRL Control DSP Down-stream processing ee Enantiomeric excess EHS Environment-health-safety E/S Ratio of enzyme used to substrate converted EU European union FAD Flavin adenine dinucleotide FDH Formate dehydrogenase G6PDH Glucose-6-phosphate dehydrogenase GB Gega bytes GC Gas chromatography GCDW Grams of cell dry weight Ghz Gega hertz HCL Hydrochloric acid HK Hexokinase  HPLC High pressure liquid chromatography IMMPBR Integrated micro membrane packed bed reactor IPA Isopropyl amine 
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ABREVIATION DESCRIPTION IPTG Isopropyl β-D-1-thiogalactopyranoside IScPR In-situ co-product removal ISPR In-situ product removal ISSS In-situ substrate supply LB Lysogeny broth LDH Lactate dehydrogenase MAO Mono amine oxidase MBA Methylbenzylamine MEMR Micro enzyme membrane reactor MPPA 1-methyl-3-phenylpropylamine MSR Microstructured reactors MTBE Methyl tert-butyl ether MWCO Molecular weight cut-off NADH Nicotinamide adenine dinucleotide NADP Nicotinamide adenine dinucleotide phosphate OD Optical density µ-PBR Microscale packed bed reactor PC Polycarbonate PDMS Polydimethylsiloxane PEEK Polyether ether ketone PES Polyethersulfone PI Process Intensification PLP Pyridoxal-5’-phosphate PMMA Polymethylmethylacrylate PSA Pressure sensitive adhesive PSE Process systems engineering PTFE Polytetrafluoroethylene  RAM Random access memory Ref Reference rpm Rotations per minute RTD Residence time distribution SPE Solid phase extraction STR Stirred tank reactor STY Space-time yield 
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ABREVIATION DESCRIPTION TA ω-transaminase WC Whole cells YY Y-junction inlet Y-junction outlet reactor 
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Symbols 
SYMBOL DESCRIPTION UNIT 
hd  Hydraulic diameter m 
µ  Dynamic viscosity kg / m. s 
U  Characteristic velocity m2 / s 
σ  Surface tension N / m 
ρ  Fluid density Kg / m3 
g  Acceleration due to gravity m / s2 
h  Height of the micro-channel m 
Re  Reynolds number  
Bo  Bond number  
Ca  Capillary number  
We  Weber number  
Pe  Peclet number  
D  Molecular diffusivity or mass diffusivity m2 / s 
Da  Damköhler number  
tτ  Species transportation time s 
rτ  Reaction time s 
eqK  Thermodynamic equilibrium constant  
( )C t  Outlet species concentration (microchannel) mmol / L 
0C  Inlet species concentration (microchannel)  mmol / L 
t  Time s 
IIDa  Second Damköhler number  
0AC  Inlet concentration (µ-PBR) mmol / L or kg / m3 
AC  Outlet concentration (µ-PBR) mmol / L or kg / m3 
maxAC  Maximum adsorption capacity mmol / g K Distribution coefficient  
eqC  
Concentration in the fluid at thermodynamic equilibrium mmol / L or kg / m3 
adsn  Amount adsorbed on to the resins mmol / g of resin 
Q  Flow rate µL / s 
AWC  Concentration on the surface of the resin kg / m2 
Ar  Adsorption rate kg / m2 s 
Dr  Desorption rate kg / m2 s 
ak  Adsorption rate constant m3 / kg s 
dk  Desorption rate constant 1/ s 
permK  Permeability coefficient m2 
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SYMBOL DESCRIPTION UNIT 
lossK  Loss coefficient m-1 
p  Static pressure kg / m s2 
τ  Stress tensor  
∇  
Gradient (partial derivative of the quantity, vector or scalar, in all three directions)  
⊗  Dyadic operator or tensor product (of two vectors)  SM External source terms  
δ  Identity matrix or Kronecker delta function  
Dϕ  Kinematic diffusivity of the scalar m2 / s 
φ  Conserved quantity per unit volume 1 / L 
ϕ  Conserved quantity per unit mass 1 / kg 
Sϕ  Volumetric source term  
γ  Volume porosity  
V  Physical volume of a cell (mesh) used for simulations m3 
V ′  Volume available to the flow in an infinitesimal control cell m3 
A  Infinitesimal planar control surface of vector area m2 
A′  The vector area available to flow m2 
K  Area porosity tensor  
eµ  Effective viscosity kg / m s 
xU  Fluid velocity, x-direction m2 / s 
yU  Fluid velocity, y-direction m2 / s 
zU  Fluid velocity, z-direction m2 / s 
PD  Particle diameter m 
S  Source term  
oS  Sphericity of the resin particles  
logP  Partition coefficient  
gP  grams of product  g  
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1 Introduction 
1.1 Background Microstructured reactors (MSR) have been successfully used in the chemical industry because of their advantages compared to conventional reactors. They are particularly suited for difficult reactions requiring extreme conditions such as highly exothermic reactions [1]. They have also been implemented successfully in multiphase reactions, fluid-fluid, fluid-solid and three phase reactions [2]. Some of the advantages of using microstructured reactors are: process intensification (PI) is achieved through improved heat and mass transport; microstructured reactors bring along an inherent process safety due to their low volume operating conditions; a broader range of reaction conditions can be exploited and faster process development is achieved. According to Stankiewicz and co-workers, any development that leads to a substantially smaller, cleaner and more energy efficient technology is process intensification [3]. Thus PI deals with developing already existing processes or creating new options with improvements to, equipment (new reactor designs, intensified mixing, heat and mass transfer intensified equipments etc), process techniques (integration of unit operations such as reaction and separation etc), operational methods (using alternative energy forms such as microwaves, electromagnetic etc) and boosting their efficiency. These developments help to produce products using cheaper and sustainable methods. In principle, many options can be generated and thus the bottleneck lies with identifying the best improvement option. Biocatalysis, the use of isolated or immobilized enzymes or cells as catalysts, is gaining increasing importance over classical organic synthesis because of its many advantages: biocatalytic reactions are characterized by regio-, stereo-, and substrate selectivity and they are generally labelled with the “green chemistry” label because of their lower E-factor and higher atom efficiency [4, 5]. The E-factor is widely used as a measure for assessing the environmental compatibility of a process [5, 6] while the atom efficiency is a measure of the amount of waste generated by process alternatives [7]. Furthermore, in the pharmaceutical industry biocatalysis is gaining momentum and now becoming a key component in the toolbox of the process chemist [4]. However the requirement of shorter lead times for process development and improved process yields for successful implementation in the pharmaceutical industry is posing significant problems for biocatalytic processes because of the increasing availability of enzymes to screen for (identifying the suitable enzyme for a specific system), the diversity of the reactions that can be catalysed and the many process techniques that are available 
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to screen for improving yield and productivity. Thus the new challenge for implementation of biocatalysis is the faster screening, process development and process intensification.  The use of microstructured systems for performing biocatalytic reactions enables rapid screening and high-speed process development including catalyst screening, process screening for economic evaluation along with design of new reactors, integration of unit operations and achieving higher productivities for industrial viability [4]. However the next big challenge is to retain the increase in productivities attained at microscale during scale-up to production scale. 
1.2 Motivation 
Recent developments in protein engineering and recombinant technology have enabled increased availability of enzymes which can be used to establish new chemistries not explored before. In order to effectively handle these new developments, new faster and effective screening methodologies also need to be developed that can handle complex processes such as biocatalysis.  There is furthermore also the necessity to develop a toolbox for overcoming different process challenges and achieving higher yields. The toolbox needs to contain tools that can be used to tackle challenges arising from both biocatalyst related and process related issues. Biocatalysis can also be integrated as an intermediate step together with other catalytic or non-catalytic steps. Thus this toolbox also needs to include easy implementation and testing of various techniques for faster process development. In order to evaluate the performance achieved through the application of various techniques, a suitable set of performance/process metrics are required. Specifically for biocatalysis. critical process metrics are defined by Tufvesson and co-workers for evaluating the biocatalytic processes for economic viability [8]. The threshold values for these metrics, however, vary depending on the targeted industrial sector (for instance pharmaceuticals versus bulk chemicals industry). Thus the motivation for the work done during this project arises from the need to develop biocatalysis tools or modules at microscale that can handle:  
− rapid collection of relevant process data to gain process knowledge 
− the possibility of screening through integrated systems or process techniques 
− efficient use of small amounts of reagents and enzymes to obtain process data 
− the integration of systems in a continuous process and the performance evaluation of a candidate process through a set of suitable process metrics  
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1.3 Objectives  The objectives of the thesis are: 
o To explore design and development of reactor configurations at microscale and to compare performance to lab-scale batch systems 
o To explore the possibility of using micro-technology and computational fluid dynamics (CFD) for gaining process knowledge that can further help with microscale reactor and process design 
o To develop customized process modules at microscale  
o To integrate different process techniques at microscale for intensified processes 
o To be able to use integrated systems for rapid and effective screening of the economic viability of the candidate process, supported by an objective set of process metrics 
1.4 Structure of the PhD Thesis Apart from this introductory chapter, the thesis contains 7 chapters, with each chapter dealing with a specific topic as described below, and a final conclusion chapter. 
− Chapter 2 introduces the microreactors and biocatalytic processes and the application of microreactors in biocatalysis along with providing an overview of different reactor configurations  
− Chapter 3 demonstrates the design and development of reactor configurations at microscale using biocatalytic transamination as a case study 
− Chapter 4 introduces some of the process techniques that can be applied to overcome various hurdles during biocatalytic process development and achieve better performance. It also introduces the reader to the process metrics required to evaluate the performance 
− Chapter 5 demonstrates the screening and characterization of adsorbent resins using µ-packed bed columns and computational fluid dynamics (CFD) 
− Chapter 6 demonstrates the concept of integrated systems for efficient operation, screening and evaluating the process performance as compared to a batch system 
− Chapter 7 deals with developing a systematic methodology for process development and discussed the various issues that need to be considered during scale-up and process design of biocatalytic processes  
− Chapter 8 summarizes the project results and includes the conclusions and a future outlook 
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2 Literature overview 
This chapter gives an introduction to microreactors and biocatalysis and shows the application of microfluidic systems for biotransformations. 
2.1 Microreactors Microreactors have been a focus of growing interest for chemical and pharmaceutical industries, because of the prospects of achieving faster reactions, higher yields, safer processes and reduced use of toxic reagents. These advantages are linked to the improved heat and mass transfer characteristics of microreactors which can be explained by the high surface/volume ratios of microreactors. Moreover they can be operated as continuous reactors and thus also benefit from the additional advantages from flow chemistry [9-11].  Thus microreactors are widely used in the industry under different reactor configurations for various applications and reactions: micro-mixers, splitting and recombining of streams, interdigitated flows, parallel flow and slug flow configurations, packed bed reactors, membrane reactors etc [12-20].  During the past years, there have been revolutionary improvements in this technology and the 2nd generation microreactors allow the integration of one or more functions onto a single chip. Micro-process technology and smart flow processing is now increasingly used for speeding-up process development for chemical reactions and process intensification [21, 22]. In the literature, one frequently refers to the three intensification fields achieved through application of micro-technology: transport intensification through increase in heat and mass transport; chemical intensification through increase in reaction rates; process design intensification through systems integration [21, 22]. As such the possibility of using microreactors for industrial production and complete plant design has been analysed over the past couple of decades [23, 24]. Companies such as Corning and DSM have established microreactors for the production of pharmaceuticals with reactors that can handle about 800 metric tons of process fluids per year and that can run for 8000 hrs of continuous operation [25]. There are many companies producing and marketing microreactors for commercial scale production: Corning, Micronit Microfluidics, Ehrfeld Mikrotechnik BTS, Future chemistry, Fraunhofer ICT - IMM, Velocys, Uniqsis, Syrris, iX-factory, Microfluidic Chipshop etc. Some of the industrial applications and intensification results achieved through the use of microreactors are highlighted in Table 2.1.   
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Table 2.1: Industrial application of process intensification achieved through use of microreactors 
Company Chemical reaction Intensification achieved Ref 
Lonza Ltd. Two-step organometallic reaction 
The microreactor can be operated at much higher flow rates as compared to a static mixer with improved product yields 
[26] 
Clariant international Ltd. Synthesis of phenyl boronic acid Improvement to product yield, reduction of side/consecutive products and energy expenditure [27] Merck  & Co., Inc., Grignard-based enolate formation Improved space-time yield [28] 
Ube Industries, Ltd. Swern oxidation Reaction performed at much higher temperatures (-20 and 20 0C) in microreactors as compared to its macroscale batch reactions (-50 0C) 
[29] 
Pelikan PBS-producktionsgesellschaft mbH & Co. Production of writing ink 
Specific waste water production was reduced by a factor of 1000 making it an eco-friendly production process [30] 
Lonza Ltd. Ozonolysis Microreactor technology has enabled fast and flexible development and scale-up to production scale [31] 
DSM Ritter reaction Yield increased by 20% compared to a batch system; Throughput of 1.7 tons/hr reaction mixture; >1000 tons of product per year [32] 
DSM Selective azidation Productivity increased to >10000 kg/m3h starting from >10 kg/m3h (batch system) [32] 
DSM Nitration reaction 
Microreactor with integrated feed preparation, nitration, quench and neutralization; achieved pilot plant production of 500 kg by numbering-up microreactors 
[32] 
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2.1.1 Microreactors – materials and fabrication In general, a wide array of materials can be used to build microreactors including polymers, glass, metals and ceramics. The earliest reactors were constructed in silicon and glass. However, polymer based reactors are gaining popularity because of their ease of fabrication, optical transparency, durability, biocompatibility and cheaper material costs. Fluidic interconnections are also widely available. Polydimethylsiloxane (PDMS), polycarbonate (PC) and polymethylmethylacrylate (PMMA) are the most widely used polymers for building microreactors [11, 33-35]. Because of their lower costs (including fabrication) polymers enable production of disposable microfluidic devices. Recently materials such as COC (cyclic olefin copolymer) are also used increasingly for building microreactors because of their inertness to many chemicals. There are many fabrication techniques for microstructuring in polymers such as micromachining [36], injection moulding [34], hot embossing [37]  and soft lithography [38]. Many of these fabrication methods enable integration of electrodes, sensors etc into microstructures and thus enable the production of custom made microfluidic devices. 
2.1.2 Microreactors – flow dynamics Flow in microfluidic channels can be single phase or multiphase. Depending on the specific application customized reactor configurations can be constructed but the most common reactor configurations are: meandering, straight and circular channels with T, Y and ψ junctions and splitting and recombining of streams. Flows in microchannels are considerably different to larger systems [39] as viscous ( hU dµ≈ ) and interfacial ( hdσ≈ ) forces are more dominant than inertial ( 2Uρ≈ )  and gravitational forces ( ghρ≈ ), where hd is the hydraulic diameter, µ is the dynamic viscosity, U is the characteristic velocity, σ is the surface tension, ρ is the fluid density, g is the acceleration due to gravity and h is the height of the channel. Because of the dominant viscous forces flow is typically laminar.  2.1.2.1 Dimensionless numbers Dimensionless numbers are used to represent the importance of forces that represent the flow. The Reynolds number (Re)  is defined as the ratio of inertial forces to viscous forces. At microscale as the viscous forces are more dominant than the inertial forces, the Re numbers are in general small indicating that the system is operated in the laminar flow regime. 
   Re hd Uρ
µ
=     (2.1) 
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The Bond number ( )Bo  is defined as the ratio of gravitational forces to surface tension forces. As the surface tension forces are more dominant in microchannels than the gravitational forces, usually Bo  are <1. 
   2hgdBo ρ
σ
=     (2.2) 
The Capillary number ( )Ca  represents the ratio of the viscous and interfacial forces. At microscale both the viscous forces and interfacial forces are dominant. Thus as the capillary number reaches critical value, droplets are formed inside the flow regime to minimize the interfacial area.   
   UCa µ
σ
=     (2.3) 
The Weber number ( )We  is defined as the ratio of inertial effects to surface tension forces. Low Weber numbers indicate dominant surface tension forces maintaining the droplets in the flow regime and as the inertial forces increase the droplets begin to deform forming concave shapes and finally break-up. 
   2 hdWe ρµ
σ
=     (2.4) 
The Peclet number ( )Pe  is defined as the ratio of convection to diffusion. At microscale, depending on the flow velocities and channel diameters, either of these can be dominant.  
   hd UPe
D
=     (2.5) 
Where D  is the molecular diffusivity. Thus for Pe  numbers smaller than 1, it can be concluded that flow is dominated by diffusion rather than convection and vice versa  Dimensionless numbers are also used for defining the convection and diffusional flows inside the channels with chemical species. The Damköhler number ( )Da  is defined as the ratio of the reaction time to the species transportation time and thus it determines the limiting factor to reaction progress.  
   t
r
Da τ
τ
=     (2.6) 
Where tτ is the transportation time and rτ is the reaction time. Furthermore. the Damköhler numbers 1 and 2 are defined if the transportation is caused by convection and diffusion respectively. Thus if Da
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is under 1 then the overall process is reaction limited and if it’s over 1 then the process studied is assumed to be transportation limited.  Stable flow patters can be obtained through the use of microreactors by obtaining a balance between inertial, viscous and interfacial forces. The different flow regimes that can be obtained for multiphase flows are parallel flow, bubble flow, slug or taylor flow and annular flow. Figure 2.1 gives a representative picture of these flow regimes.  
Parallel Flow
Bubble Flow
Slug or Plug Flow
Annular Flow  Fig 2.1: Flow regimes 
2.1.3 Computational fluid dynamics (CFD) Modelling of the flow in microchannels contributes to understanding the physical phenomena occurring inside the microchannels. These phenomena depend on the channel geometry, properties of fluids and flow conditions. Computational fluid dynamics (CFD) is the science of predicting fluid flow, including other physical phenomenon such as heat and mass transfer characteristics and chemical reactions, by solving mathematical equations that represent physical laws using numerical methods. CFD analysis can be broadly classified into four steps: geometry creation, mesh generation, simulation and post-processing. The first step involves creating the geometry or computational domain using software tools. The grid (mesh) is generated in the second step where the computational domain is decomposed into smaller volumes/elements. The mesh should be sufficiently fine to resolve the flow along with other physical phenomena. The type of meshing strategy (course or fine mesh, number of tetrahedral and hexahedral elements etc) and the quality of the mesh (number of skewed elements etc) has a huge impact on the complexity of computations and the preciseness of solutions. It also has a huge impact on the computational time and effort required for solving the CFD model. Thus it is 
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important to identify the trade-off between the preciseness of solutions and the required computational effort. The fluid properties, and the physical and chemical phenomena that need to be modelled are defined in the third step. Appropriate boundary conditions and constraints are defined. With the specified operational parameters, simulations can be performed to identify flow behaviour and flow regimes. Multiphase modelling can be performed by defining the phases for instance to determine the mass transfer characteristics. Post-processing of the simulation results is performed in order to extract the desired information from the simulations.  
2.2 Biocatalytic processes Biocatalytic processes, which enable highly chemo- and stereo- selective reactions, are gaining interest in both the bulk and the pharmaceutical industries and are replacing conventional processes as a consequence of better quality and economic profitability [40-43]. However, enzymes have to operate under typical industrial conditions in order to yield an economically viable process and these conditions are far from the natural conditions of the enzyme. For an economic and environmentally sustainable process, some requirements such as the biocatalyst productivity, substrate utilization etc needs to be maximized [44-47]. Presently there are more than 150 industrial scale processes that are known to use enzymes or whole cells in either free or immobilized forms [48-51]. The production scale of these processes is more than 100 kgs per annum. Biocatalysis can often also be integrated with traditional chemical synthesis steps [52] and can also be used for removing undesired products rather than making desired products. Most of the biotransformation products are fine chemicals including pharmaceutical intermediates. The stereoselectivity of enzymes is increasingly applied to produce pure enantiomers thus achieving higher enantiomeric excess (ee) values. Enantiomeric excess is a measurement of purity of chiral substrates and is defined as the absolute difference between the mole fractions of each enantiomer in the mixture. The implementation of biotransformation processes at an industrial scale is doubling every decade [53]. Some of the industrial scale production processes that include one or several biocatalytic steps are highlighted in Table 2.2. The resulting product can be an API (active pharmaceutical ingredient) or an intermediate for further synthesis to the final product.       
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Table 2.2: Industrial scale biocatalytic processes  
Company 
Active ingredient or 
intermediate 
Improvement achieved/ 
Challenges addressed 
Ref 
Merck & Co. Sitagliptin phosphate 
Compared to the chemical catalytic process 10 to 13% increase in overall yield, 53% increase in productivity (kg/L per day) and 19% reduction in total waste achieved; 97% conversion with 57% yield achieved 
[40] 
Codexis Hydroxynitrile (key intermediate for manufacture of Atorvastatin) 
Two-step three enzyme process with ~2500 fold increase in volumetric productivity per mass catalyst load; 14 fold reduction in reaction time; 7 fold increase in substrate loading; 50% improvement in isolated yield 
[41] 
Bristol-Myers Squibb 
(S)-3-hydroxyadamantylglycine (key intermediate for the synthesis of  Saxagliptin) 
100% ee achieved; process scaled-up to convert several hundreds of kilos of keto acid to (S)-amino acid [54] 
Pfizer (S)-3-(aminomethyl)-5-methylhexanoic acid (Pregabalin) 40-45% increase in yields and 5-fold decrease in E factor (86 to 17) [55] 
Bristol-Myers Squibb 
(5S)-5-aminocarbonyl-4,5-dihydro-1H-pyrrole-1-carboxylic acid, 1-(1,1-dimethylethyl)ester (key intermediate for the synthesis of  Saxagliptin) 
Yield of 71% and 98% (with inclusion of adsorbents for by-products) achieved as compared to chemical routes reaching yields from 57 to 64% 
[56] 
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Schering-Plough Research Institute 
prochiral diethyl 3-[3',4'-dichlorophenyl]- glutarate (intermediate in the synthesis of a series of neurokinin (NK) receptor antagonists) 
97% conversion achieved at 100 g/L of substrate concentration; 200 kgs of product produced with ee>99% and average isolated yield of 80% 
[57] 
NovoNordisk S-2-ethoxy-3-(4-hydroxyphenyl)propanoic acid (key intermediate in the synthesis of Ragaglitazar) 
44 kgs of pilot scale process developed with 43-48% yields and ee of 98.4% - 99.6% [58]  
2.3 Microreactors in biocatalysis The development, optimization and application of micro-flow reactors for enzymatic processes is expected to accelerate the process development and process intensification by offering rapid acquisition of the data and effective screening through reduced usage of expensive enzymes and reagents [53, 59-66]. Microreactor processing also allows for better and easier control of reaction conditions such as temperature, which has a direct impact on the enzyme activity. Thus, application of micro-technology for biocatalysis allows for achieving intensified processes [39, 60, 66]. Microreactors can be easily fabricated to a custom design and thus allow for easy integration of more than one functionality on a single chip. Achieving process intensification can be supported by gaining process knowledge through modelling and experimentation. It also helps furthermore to screen the entire process under process relevant conditions to check for the economic viability even during early stage process development. Thus as described by Hessel et al., enzymatic micro-flow reactors as compared to its chemical counterparts is a relatively new discipline but with a huge enthusiasm [61].  The use of miniaturized systems (microwell plates; mini/micro bioreactors or systems) has contributed significantly to intensifying the biocatalytic process development over the past decade [67]. Microsystems have found their way into different steps during the development process including the biocatalyst screening, the generation of libraries and the selection of operational conditions for biocatalyst production and enzymatic reaction and enzyme immobilization [68-79]. Microwell plates have been widely used for screening [80], characterizing [81] and also evaluating the kinetics of biotransformation systems [82, 83]. Multi-well plates embedded with sensor spots have been commercialized and are used to rapidly acquire on-line data. However mixing in such systems is 
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by shaking rather than stirring, where stirring is the preferred mixing approach used in most large scale reactors. Thus the small-scale systems have different mass transfer phenomena and fluid dynamic characteristics compared to the large scale systems, which makes direct scale-up challenging. Microfluidic reactors, which enable different reactor configurations and are compatible with continuous operation, are recently gaining importance in process development. For instance a simple reactor configuration is to use the single liquid phase flow system in a microchannel where the substrate and the enzyme aqueous solutions have different inlets and the streams are combined for the reaction to take place along the length of the channel. The dimensions of the channel can be customized to increase the reaction efficiency. The microchannel can be a straight channel, a meandering channel, a zigzag channel etc. Table 2.3 highlights some of the different reactor configurations reported in the literature as well as the increased performance that has been achieved: Table 2.3 Different microscale reactor configurations for biocatalysis for increase in performance 
Microreactor configuration Biotransformation system Comments Ref Y-junction microfluidic channel as electrochemical microreactor in which two liquid streams merge and flow laminarly between electrodes 
Coupled enzyme reactions using FDH for cofactor regeneration and LDH  for in situ conversion of pyruvate into L-lactate 
Used effectively for electrochemical regeneration of co-factor NADH using FAD/FADH2 as the mediator and subsequent biocatalytic conversion 
[84] 
Straight channel with static mixing (laminar flow distribution) (0.25<Re<62.5) using triangular packing features 
Breakdown of hydrogen peroxide into oxygen and water in the presence of catalase 
Conversion increases significantly compared to empty channels (channels without static mixers) 
[85] 
Y-junction microchannel with multiphase parallel flow, n-hexane and substrates and buffered enzyme solution fed from each inflow 
Synthesis of isoamyl acetate catalysed by lipase using acetic acid as acetyl donor Much faster reaction rates as compared to batch system [86] 
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Tubular microchannel with multiphase segmented flow of aqueous phase (enzyme) and hexane 
Enzymatic oxidation of hexanol to hexanal 
In a 6µL reactor 11.78% conversion of hexanol was attained in 72 seconds  compared to 5.3% conversion in 180 seconds in macroscale 
[87] 
Micro-channel embedded with (neodymium-iron-boron, NdFeB) magnet and packed with magnetic beads 
Enzymatic (diaphorase) conversion of resazurin to resorufin 
Conversion was more than twice compared to batch system [88] 
ψ-junction inlet for separate inflow of ionic liquid, enzyme and isoamyl alcohol; enzyme and isoamyl alcohol; and n-heptane. Y-junction at the outlet. 
Synthesis of isoamyl acetate in n-heptane, catalysed by lipase and with acetic anhydride as acyl donor 
The system is run for simultaneous reaction and product recovery; a 3-fold increase in reaction rate was observed compared to a batch system; parallel and slug flow regimes can be achieved depending on the flow rates 
[89] 
T-junction straight channel microreactor with staggered herringbone micromixer and an in-line filtration system (using membrane) 
Transketolase catalysed reaction of lithium hydroxypyruvate and glycolaldehyde to L-erythrulose 
Complete conversion of the substrate to product has been achieved with complete retention of the enzyme [90] 
Microfluidic multi-input meandering channel microreactor with multiple inlets for substrate addition 
Transketolase catalysed reaction of lithium hydroxypyruvate and glycolaldehyde to L-erythrulose 
4.5 fold increase in output concentration and 5-fold increase in throughput compared to single input reactor 
[91] 
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3 Microreactors and CFD as screening tools for 
reactor design 
This chapter demonstrates the advantages of performing biotransformations at microscale with the aim of gaining process knowledge for developing reactor configurations that suits the needs of the specific biocatalytic process, and using the biocatalytic synthesis of chiral amines as a case study. This chapter is based on pre-published work [92]. 
3.1 Synthesis of optically pure chiral amines Enantiopure chiral amines are of considerable commercial value because of their many applications as: resolving agents [93, 94], chiral auxiliaries [95], pharmaceutical intermediates [96] and catalysts for asymmetric synthesis [97]. Table 3.1 illustrates some of the Industrial pharmaceutical compounds containing the chiral amine group. Table 3.1 Industrial Pharmaceutical compounds containing a chiral amine group (Adapted from [40, 98]) 
Compound Structure Drug action Company 
Codeine  Pain relief drug Johnson Matthey 
Sitagliptin phosphate  Anti-diabetic drug Merck 
Sertraline  Anti-Depression drug Pfizer 
Repaglinide  Anti-diabetic drug Novo Nordisk 
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Compound Structure Drug action Company 
Rivastigmine  Alzheimers disease Novartis 
Methadone – racemate  Narcotic analgesic Generic 
Flomax/Tamsulosin 
 
Prostate Boehringer Ingelheim 
Sibutramine  Obesity Abbott Labora Tories 
Cinacalcet  Hyperpara thyroidism Amgen 
Lariam 
 
Malaria Roche 
Ethambutol  Tuberculosis Generic 
Lopinavir  HIV-protease inhibitor Abbott Labora- tories 
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Chiral amines can be synthesised by kinetic resolution [99], diastereomer crystallization [100] and asymmetric synthesis [99]. Kinetic resolution and asymmetric synthesis can be performed using chemical catalysts or using enzymes. Kinetic resolution is the process where the undesired enantiomer is reacted and thus increasing the enantiomeric purity of the racemic mixture. Thus the maximum conversion of the desired enantiomer that can be achieved is only 50% in a single step. Asymmetric synthesis is the chiral synthesis of non-chiral molecules to a chiral product. The theoretical yield of asymmetric synthesis is 100%.  
3.1.1 Model reaction scheme Biocatalysis is one of the greenest technologies for the production of chiral amines because of its high enantiomeric selectivity and the process operation under mild conditions [101, 102] and also since developing efficient chemical routes for synthesis of chiral amines still remains a challenge [103]. The biocatalytic transamination for the production of chiral amines by asymmetric synthesis [103, 104] is studied intensively nowadays, mainly because the transamination reaction is attractive for synthesis of pharmaceuticals and precursors. Transamination is thus commercially attractive, but also involves quite a number of challenges related to developing such a process [103]. The ω-transaminase (TA) catalysed synthesis of (S)-(-)- α-Methylbenzylamine (MBA) with acetone (ACE) as co-product, and using acetophenone (APH) and Isopropylamine (IPA) as starting materials has been selected here as the case study (Fig. 3.1). The reaction is catalysed in the presence of a co-factor Pyridoxal-5’-phosphate (PLP), by transferring the amine group from the amine donor to a pro-chiral acceptor ketone, yielding a chiral amine along with a co-product ketone. The reaction follows the ping pong bi-bi mechanism where the substrate is bound first to the enzyme while co-product is released before the second substrate and the final product leaves the enzyme. Kinetic models for this reaction have been reported in the literature [105, 106].   
 Fig 3.1: Biocatalytic transamination by ω-Transaminase  
C H 3 + C H 3 + 
(S)-(-)- α 
2 
C H 3 C H 3 2-propylamine  (IPA) 
O 
C H 3 C H 3 Acetone (ACE) 
(s) -ω-transaminase PLP 
O N H N H 2 
Acetophenone (APH) -Methylbenzylamine (MBA) 
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3.1.2 Challenges Tufvesson and co-workers have highlighted some of the challenges that need to be addressed during process development of this reaction: unfavourable thermodynamic equilibrium, inhibitions of enzyme activity at higher concentrations of substrate and product, low aqueous substrate solubility and limitations with respect to enzyme stability and activity [103]. The main challenges represented 
here are the most common challenges faced in the asymmetric synthesis of chiral amines using ω-transaminases. As such developing reactor configurations for this system can be widely applied to suit other reactions using ω-transaminases.  3.1.2.1 Substrate and product inhibitions Inhibition of the enzyme activity is one of the main issues in many enzymatic reactions. The inhibitor molecule reversibly binds to the enzyme slowing down its conversion rate. Thus the higher the concentration of the inhibitor, the slower is the enzyme activity. There are three types of enzyme inhibitions based on the inhibition molecule binding site: competitive, uncompetitive and non-competitive inhibition. In all the cases the inhibitor molecule binds to the enzyme affecting or reducing the active sites for substrate binding.  3.1.2.2 Thermodynamic limitations The maximum conversion that can be obtained in any reaction is bound by the equilibrium constant, 
eqK . This parameter is independent of the biocatalyst and depends only on the thermodynamic properties of compounds. For the specified reaction the eqK value is calculated by Tufvesson and co-workers [107] to be 1/30 which indicates that thermodynamic equilibrium is strongly in favour of the substrates. A conventional method for estimating the equilibrium constants is to allow the reactants to reach equilibrium from both directions (forward and backward) of the reaction. However the authors have used a modification to the conventional method due to the slow reaction rates and other issues such as degradation or evaporation of the reactants. The modified method was based on using varying compositions of the reactants and products to find the point where the forward and the reverse reactions converge to give a zero net reaction. Lower equilibrium constants indicate the need for some process strategies (such as excess amine donor) or customized reactor configurations for shifting the equilibrium to attain higher yields.   
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3.2 Process development at microscale It has been demonstrated before that microreactors can be used as an effective tool to assist in achieving the optimal reactor design for overcoming process challenges for chemical processes [108]. As discussed in chapter 2, different reactor configurations can be obtained based on the specific application. Thus here it is intended to build and test customized reactor configurations for achieving higher yields. Micro-scale devices, because of their ease of fabrication, are especially advantageous for testing various reactor configurations. CFD is also used as an important supporting tool to model the fluid dynamics inside the channels. Thus, combining experiments with advanced data interpretation while developing a continuous production process, microscale devices can be effectively used for screening different reactor configurations. 
3.2.1 Chemicals Technical grade reagents were procured and used without further purification. The chemicals (S)-(-)-
α-Methylbenzylamine (MBA), Acetophenone (APH), and H2KPO4 were procured from Fluka analytical. Isopropylamine (IPA) and K2HPO4 were procured from Sigma-Aldrich and Hydrochloric acid (HCL) was procured from Merck.  The unpurified enzyme ω-transaminase (ATA-40) was obtained from c-LEcta Gmbh (Leipzig, Germany) as lyophilized powder. In all experiments the enzyme amount was referred to as the number of grams of unpurified lyophilized powder (cell free extract - CFE). 
3.2.2 Analysis A reverse phase HPLC method (Ultimate 3000 HPLC equipped with a UV detector and photodiode array detector) was used for determination of substrate and product concentrations. A Luna® 3 µm C18 (2) 100 A (50x4.6mm) column (Phenomenex) was used to detect the compounds at a flow rate of 2 mL/min using a multistep gradient flow of aqueous 0.1%(v/v) trifluoroacetic acid and acetonitrile (99.8%) with the following volume percentage of acetonitrile: 0 min (5%), 1 min (10%), 2.5 min (10%), 5.9 min (60%), 7 min (5%). The compounds were quantified at wavelengths of 280 nm for APH and 210 nm for MBA, with retention times of 4.8 and 1.7 minutes respectively.   
3.2.3 Microreactor – design and fabrication The microchannels were patterned in a PMMA plate (Nordisk Plast), often referred to as Plexiglas, a material that is widely used as biocompatible material [109], by a CNC assisted micro-milling technology. The micro milling machine, Mini-Mill/3, was procured from Minitech Corporation (USA) and the spindle and controller, E3000C, were procured from NSK America Corp (Nakanishi Inc.). PMMA plates of 100x100 mm (length x width) and of varying thickness (1.5–20 mm) and several end 
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mills with diameters ranging from 500 µm–3 mm were used for the fabrication of microreactor prototypes. SolidWorks (Dassault Systèmes SolidWorks Corp.) was used for creating the geometry and SolidCam for generating the G-code (numerical control programming language used for controlling automated machine tools) for the milling machine. After milling, the plates were cleaned with water followed by drying with compressed air. In order to seal the reactor, an upper plate without any channels was then adhered on top of the bottom plate which contains a reactor pattern created with the micro-milling machine. Double-Coated PSA Tapes (pressure sensitive adhesive) with medical grade adhesive was procured from Adhesive research Inc. (USA) and is used to adhere both plates together.  
3.2.4 Equilibrium tests The first step during the development process is to check for the affinity of chemicals to materials used for fabricating the microreactor (adsorption/absorption properties). Equilibrium tests were performed in a 4 ml glass vial with different concentrations of substrate and product. Pieces of PMMA were suspended inside the vials and the concentrations measured after 1 and 3 days.  Similar experiments were conducted to test for the adsorption/absorption of chemicals to different materials used for tubing and sampling. (Appendix 1a). The results show no adsorption/absorption of chemicals to PMMA (Fig 3.2). 
a) b)  Fig 3.2 Equilibrium tests of substrate and product 
3.2.5 Experimental set-up The experimental set-up (Fig 3.3) consists of a Modular digital pump, Cavro XL 3000 from Cavro scientific instruments Inc., with two syringes (controlled using the software LabView), Polytetrafluoroethylene (PTFE) tubings, a microreactor  and a microscope. The experiments were performed under continuous flow conditions. The experimental design, in terms of loading and pumping steps, was coded in LabView. For pictures of the set-up, pump and LabView codes please refer to Appendix 1b.  
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Product
 Fig 3.3: Experimental set-up: Syringe pumps, A and B, have one inlet and two outlets, one to the reactor and another alternative outlet  The system was primed by flushing the pumps in order to reach steady state conditions before starting the experiments. As can be seen in Fig 3.4, the system needs 5 cycles of priming to reach steady state. This can be attributed to the dead volumes from the 3-port distribution valve and further the adhesion of the molecules to the walls of the valve and the tubing system. Thus before starting each experiment the system is primed for 5 cycles.  
 Fig 3.4: Priming the reactor system 
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3.2.6 Reactor configurations  Batch reactions with different residence times were performed in a 4 ml glass vial with a magnetic stirrer (300 rpm) (Fig 3.5a) and were used as a reference to evaluate the performance of the microreactor configurations. To overcome the process challenges, unfavourable thermodynamic equilibrium and inhibitions, it was intended to fabricate a laminar parallel flow reactor configuration (Fig 2.1) where substrate and enzyme can be fed as separate streams and the product can be extracted continuously to shift the equilibrium. The efficiency of extraction would depend on the interfacial contact area and the diffusional properties of the substrate and product. In order to obtain a laminar parallel flow a YY-junction straight channel micro reactor with a Y-inlet and Y-outlet and a straight channel of size 100 x 0.55 x 1 mm (length x width x depth) was fabricated. The length and the width of the channels can be optimized based on the reaction and species transport characteristics. The sizes of the inlet and outlet channels were 10 x 0.55 x 1 mm and 5 x 0.55 x 1 mm, respectively. The reactor thus can be used for combining two inlet streams and splitting them again at the outlet as shown by arrows in Fig 3.5b. It can also be used as a single channel reactor by closing one inlet and/or one outlet. Another reactor configuration consists of three parallel plates with 2 inlet streams at the top and bottom plates respectively, and an outlet in the middle plate, Fig 3.5c. The streams in top and bottom plate are divided into 4 sub streams, and are then combined at the entrance of the channel in a middle plate to form an interdigitated flow as represented by arrows and interface lines in Fig 3.5c. The length and depth of the microchannel for this reactor is the same as for the YY reactor, 100x1 mm. The width varies between 25-0.55 mm as the interdigitated flow is directed from a wider triangular area into a narrower channel as shown in the Fig 3.5c.  
3.3 Experiments and results: 
3.3.1 Laminar flow The channel dimensions are sufficiently small and the flow rates are sufficiently low to maintain a laminar flow. The Reynolds numbers for different flow rates used for experiments were between 0.2 -1.5, confirming the laminar flow regime. Visual experiments using coloured dyes were also performed to confirm the laminar flow along the length of the channel (Appendix 1d).    
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Fig 3.5: Reactor configurations: a) 4 ml Glass vial with magnetic stirrer; b) YY channel reactor, volume 50 µL; c) Top view (right) and side view (extreme right) of the 8 stream reactor (8S), volume 245.5 µL. The dimensions of the reactors are mentioned along with the views. The mechanism of combining the streams from the top plate and the bottom plate into the middle plate for 8S is shown with arrows 
            
 
3.3.2 Residence time distribution (RTD)  Transient experiments were performed with a step change at the inlet and measuring the concentration profile at the outlet in order to obtain the residence time distribution (RTD) profiles. Following a step input of a diffusing species at the inlet at time t=0, the phenomenon of species transport in uniform poiseuille flow is explained by the convection-diffusion equation [110]. A species that is diffusing relatively fast creates a more radial mixing profile (Fig 3.6a) and a species diffusing more slowly has less effect on the laminar flow regime (Fig 3.6b). The non-dimensional RTD is governed by equation 3.1. The RTD profiles are helpful in understanding the diffusional properties of 
Stream 1 Stream 2
Outleta) b) c) 
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the species. Slowly diffusing species have more lag time, and thus it takes more time to reach the normalized concentration at the outlet. The first molecules of the species will also break through faster at the end of the channel compared to relatively faster diffusing species (Fig 3.6b). Relatively faster diffusing species (Fig 3.6a) have a more plug flow behaviour because of the dominating diffusion over convection which is different from the plug flow arising due to turbulent conditions.    ( ) ( )
0
C t
E t
C
=     (3.1) 
Where 0C  is the species concentration at the inlet for a step input, and ( )C t is the concentration measured at the outlet at time t. 
a)  b)  Fig 3.6: Uniform poiseuille flow behaviour of a) relatively faster diffusing species b) slow diffusing species The YY reactor configuration described in Fig 3.5b is used for the RTD experiments. Only one inlet and outlet of the YY reactor are used for this experiment while sealing the others. Experiments were performed at a flow rate of 7.5 µL/min. To gain more understanding of the diffusion properties of substrate and product, a step input is induced at an inlet of the Y-junction after reaching a steady state flow condition, while the concentration over time is subsequently measured at the outlet in order to obtain the response curves to the step input (Fig 3.7). Glucose with a known diffusion coefficient of 0.67*10-9 m2/s, was used a reference compound. Please refer to appendix 1c for details of glucose analysis.   In Fig 3.7 it can be observed that the RTD profile for substrate (APH) is much slower in reaching the normalized concentration of 1 compared to that of the product (MBA). This might indicate that the diffusion of APH is considerably slower compared to MBA. From the profiles (Fig 3.7) it can also be seen that the MBA curve overlaps with the reference curve for glucose, meaning that the diffusion coefficient of MBA is much closer to the diffusion coefficient of glucose, which is 0.67*10-9 m2/s, compared to the substrate APH. It is of interest to determine the aqueous diffusion coefficients of these compounds for optimal reactor design. Southard et al. have demonstrated the usage of Taylor’s method of hydrodynamic stability to experimentally determine the aqueous diffusion coefficients [111]. Other methods of determining the diffusion coefficients of a species have also been demonstrated in the literature [112, 113]. However, in this approach it is intended to make CFD 
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models of the flow behaviour with manually induced diffusion coefficients with the intention to distinguish between fast diffusing and slow diffusing compounds i.e., compounds with differences in orders of magnitude of their diffusion coefficients. Though both the substrate and the product molecules have similar molecular weights and boiling points, they have quite different aqueous diffusional properties. This can be attributed to the intra-molecular attractions. 
 Fig 3.7: Normalized species concentration at the outlet from diffusion experiments for substrate (APH) and product (MBA) (outliers are marked with a circle at t = 1680 s and t = 2010 s). Glucose with known diffusion coefficient is used as reference compound. Flow rate: 7.5 µL/min 
3.3.3 CFD model and simulations The CFD model of the YY channel reactor configuration was built, simulated and analyzed using the software Ansys Fluent 12.1 (ANSYS, Inc.). The geometry was first constructed in the software SolidWorks and exported to Fluent for meshing and further model set-up, simulation and post processing. The reactor geometry was meshed with 276,841 polyhedral cells containing 1,678,788 faces and 1,383,738 nodes. The species transport model in Fluent, which uses the convection-diffusion equation, was used for setting up the diffusion of species. The mixture consists of a diffusing species and water as the medium. The properties of the mixture-template are altered to test for different mass diffusivity (m2/s) values. At the inlet boundary condition, the mass fraction of the diffusing species is set to zero at start when solving for steady state condition to obtain the velocity field by solving the equations for laminar flow. Transient simulations were then performed by giving a step input, by changing the species mass fraction to 1, at the inlet. A surface monitor is set to calculate the vertex 
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average mass fractions at the outlet for every iteration.  The data are presented as a function of flow time in order to obtain the RTD profiles.  Simulations, as described, were performed by manually inducing 2 different mass diffusivity values of a diffusing species in aqueous media. The RTD profiles (Fig 3.8) with slower diffusion coefficients show a certain time lag to reach the normalized concentration of 1 at the outlet. This lag is only dependent on the flow behaviour which in this case only varies with the diffusion coefficients of compounds. Comparing the experimental data from transient experiments to the RTD profiles from simulations one can gain an insight into the diffusional properties of the compounds. The simulation of RTD profile for the species MBA (Fig. 3.8) fits well with the data indicating that the diffusion coefficient of MBA is close to 0.67*10-9, the diffusion coefficient used in the simulation. With respect to APH (Fig. 3.8), the simulation doesn’t fit exactly with the data but it can be anticipated that the diffusion coefficient of APH is in the order of magnitude of 10-12. Thus it can be concluded that the substrate is diffusing considerably slower, at the order of 1000 times, than the product.  
 Fig 3.8: CFD simulations with induced diffusion coefficients of 0.67*10-9 and 0.67*10-12 plotted as continuous lines; Experimental results are plotted as markers  
3.3.4 Separation of streams –Steady state flow To further confirm the findings, it was intended to perform steady state experiments with 2 laminar parallel flow streams. The YY reactor is used for this experiment with substrate/product as the diffusing species at one inlet and water at the other inlet (Fig 3.9a). Both the inlets and outlets of the 
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YY reactor are used for this experiment. The concentrations are measured at the outlet of the two streams and this gives an indication of the diffusional capabilities. The separation of the streams might also depend on factors other than diffusion, like the total flow rate of the two streams as well as slight differences in pumping rates. The results (Fig 3.8b) indicate that the product (MBA) is relatively more mixed into the two streams than the substrate (APH), confirming the earlier result from the simulations. Because of the laminar flow behaviour the mixing between the two parallel flowing streams is only by diffusion. Thus the relatively faster diffusing species is more mixed from the high concentration stream to the low concentration stream and the concentrations can be measured at the outlet (Fig 3.8b). From the RTD experiments, simulations and steady state experiments, it can be concluded that the substrate is diffusing considerably slower compared to the product. 
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b)  Fig 3.9: a) Steady state combination and separation of two laminar parallel flow streams: a pure aqueous stream and an aqueous substrate/product stream; the flow rate of each stream is 33.33 µL/s and 500 µL of sample collected for each point from each stream b) Normalized concentrations at the outlet of the two streams are plotted 
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3.3.5 Biocatalysis in microreactors For the biocatalytic experiments, the reaction mixture composition can be found in Table 3.2. The pH was maintained at 6.0 by addition of potassium phosphate buffer to the reaction mixture. Samples of 200 µL were taken from the continuous flow streams. Samples are collected at the outlet of the system over different time intervals based on the flow rates and directly into vials containing 800 µL 1M HCL to stop the reaction. The samples from the reaction experiments were then centrifuged for 5 min at 14000 rpm (Minispin plus) before further analysis. Table 3.2: Concentrations of compounds used for experiments 
Compound 
Reaction 
mixture 
Concentration Isopropylamine (IPA) 2 M 
Acetophenone (APH) 20 mM 
Pyridoxal-5’-phosphate (PLP) 4 mM Enzyme concentration (ATA 40) 6 g/L  Experiments were initially performed at batch scale in a 4 ml vial (Fig. 3.5a) with good mixing using a magnetic stirrer (300 rpm), to optimize the operational parameters pH and temperature. Optimal production was obtained at pH 6.0 and a temperature of 30oC (data not shown). The well mixed batch reactor is supposed to have a homogeneous mixing profile with no diffusional limitations of species transport. These experiments at batch scale are used as a reference to benchmark the performance of other configurations. Experiments were then performed in both the YY-channel (Fig. 3.5b) and 8 stream reactor (Fig. 3.5c) configurations. Three residence times, 6.6, 30 and 60 min, were chosen in order to quantify the performance of the reactors (Table 3.3).    
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Table 3.3 Residence times and flow rates  
Residence 
time (min) 
Flow rates (µL/min) 
YY channel reactor     8S reactor 6.66 7.5 36.76 30 1.67 8.18 60 0.83 4.09 
The YY channel reactor is used for combining the two inlet streams, the enzyme stream (the reaction mixture excluding the substrate) and the substrate stream, to form two laminar parallel flowing streams. Most enzymes are significantly larger compared to their respective substrates and thus are diffusing slowly compared to the substrate. When the two streams are joined together in a Y-junction, to form a parallel laminar flow, substrate diffuses faster (than the enzyme) into the enzyme stream and reacts to form the product while the relatively slower moving enzyme stays on its side of the channel [114, 115]. Thus at the contact surface of the enzyme stream and the substrate stream, a reaction zone is formed (Fig 3.10). In the reaction zone the concentration of the enzyme and substrate are both non-zero. This reaction zone grows wider asymmetrically, with more substrate diffusing into the enzyme stream compared to enzyme diffusing into the substrate stream (Fig 3.10). Thus closer to the inlet Y-junction, the zone is less wide and grows wider along the length of the channel. Thus, closer to the Y-junction there is also less reaction as the diffusivity of the substrate limits the reaction and far downstream, with more substrate mixed, the reaction is limited by the kinetics. The width of the zone thus depends on the flow rate and the substrate diffusivity. The faster the flow the less wide will the reaction zone be, and vice versa.  
 Fig 3.10: Schematic illustration of the formation and growth of the reaction zone along the length of the channel 
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The substrate molecule in the reaction zone binds to the enzyme to form an intermediate [E.S] complex. This complex further produces the product. Thus the product concentration increases in the reaction zone along the length of the channel. Because the diffusivity of the product is much larger than the [E.S] complex, it spreads more by diffusion whereas the concentration profile of the [E.S] is relatively sharp. According to Ristenpart and co-workers [115], the concentration of the product will increase along the length of the channel (x) as a function of the channel length to the power of 5/2 (x5/2) if the reaction follows Michaelis—Menten kinetics irrespective of the initial substrate concentration and the enzyme concentration. For this transaminase catalysed synthesis reaction (Fig 3.1), as discussed earlier, a model has been described by Al-Haque et al. [105], which shows substrate and product inhibitions. Thus the average product formation is expected to be slower than x5/2 because of the inhibitions. Although the initial production rate should be close to x5/2, as the concentrations of the substrate and product increase, the rate of production indeed decreases along the length of the channel due to substrate and product inhibitions.  The concentration of the substrate in the reaction zone is lower than in the substrate stream and as the reaction only happens in the zone this indicates higher reaction rates as compared to the well-mixed batch reactor which has the concentration as in the substrate stream. Thus the YY channel reactor configuration is expected to perform better than the batch reactor because of higher reaction rates.  This is confirmed in the experimental results (Fig 3.12) where the yield from the YY reactor is higher than the well mixed batch reactor for two residence times. This confirms that the widely used continuously stirred tank reactors are not the ideal reactors for this process. For the residence time of 6.6 min the yield from the batch reactor is small and it was not possible to analyze this sample with the analysis methods used. Further extending the concept, an 8 stream reactor configuration was fabricated, as shown in Fig 3.5c, where the 2 inlet streams are subdivided into 8 sub-streams and combined to form an interdigitated flow (Fig 3.11). Thus, the 8 stream reactor has 6 more contact surface areas for diffusion compared to the YY reactor configuration. This enables a much faster mixing of streams by diffusion due to reduced diffusion path lengths. The reaction zones where the substrate and enzyme concentrations are non-zero also grow wider along the length compared to the YY-channel. Thus one can expect that the product formation should increase 6 times as there are 6 more contact surfaces for diffusion if the species transport was the bottleneck rather than the reaction kinetics. These studies also help in understanding the interaction between the species transport and the rate limitations which is defined by the Damköhler number ( IIDa ). Experimental results show an increased production compared to the YY-channel reactor and the batch reactor (Fig 3.12). However the yield was not 6 times higher as 
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expected. This indicates the shifting of the bottleneck from the species transport limitation to the kinetic limitation ( 1IIDa ≤ ).         Fig 3.11: Interdigitated flow of the 8 stream reactor represented by two coloured dyes 
 Fig 3.12: Comparison of experimental results for batch, YY-channel and 8 stream reactor for three residence times 
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3.4 Discussion As discussed before, fluid flow and species transport are the key issue in microfluidics which depend on channel geometry, properties of fluids and flow conditions. Different reactor configurations can be achieved based on the flow and species transport characteristics. The YY channel microreactor configuration is a fairly simple configuration and much easier to fabricate, and can be quite useful for gaining more process understanding. Various experiments can be performed relatively easily with low reagent consumption to quickly acquire relevant process data.  In this case study, it has been demonstrated to contribute to the understanding of the diffusional properties of substrate and product. The results are further confirmed using CFD simulations by testing 2 diffusion coefficients that showed a fairly good fit with the experimental data. With the continuous increase of computational power, these simulations can be executed relatively quickly (less than an hour for one simulation using a 2.67Ghz processor with 6 GB RAM) for different scenarios of alternating diffusion coefficients. This would however also depend on the mesh elements (type, size, quality) and the discretization schemes used. The 8S reactor configuration is built from the knowledge that the substrate is diffusing slowly compared to the product, and it was expected that increasing the contact surfaces would increase species transport. Thus it is expected to have more reaction and thus more product formation in the 8S reactor, compared to the other configurations that have been tested. However as discussed before the rate of production depends both on the species transport and kinetic limitations. It is anticipated that the ideal scenario would be where the species transport time is almost the same as the reaction time    ( 1IIDa = ) as this has the specific advantage of overcoming the substrate inhibition as the substrate concentration remains low in the reaction zone. The product, which is diffusing much faster compared to the substrate and enzyme, spreads into the other streams from the reaction zone thus reducing the concentration of the product in the zone. This has the significant advantage of overcoming the product inhibition and shifting the thermodynamic equilibrium which is a key limitation for this reaction. Thus it is expected to obtain higher productivities in the 8S reactor, and this is confirmed from the experimental results (Fig 3.12), where the yield from the 8S reactor is higher compared to the YY reactor and the batch reactor.  Such microreactor configurations also require small volumes of reagents. Obtaining data from the 4 ml batch reactor for three different residence times 6.66, 30 and 60 min requires about 1.33 ml for each data point. The analytical method used in section 3.2.2, requires a minimum sample volume of 200 µL. With the continuous production at microscale and the constraint from the analytical methods, the 
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microreactor configurations require 200 µL for each data point. The consumption of reagents during the ramp-up of the experimental set-up, Fig. 3.4, in order to obtain the steady state condition before sampling, is not taken into consideration. Thus compared to the 4 ml batch scale, a 6 times higher number of experiments can be performed with YY and 8S reactor configurations consuming the same volume of reagents. Such microreactor based platforms can also be used as an effective tool for screening experiments with varying substrate and enzyme concentrations, and process conditions. As protein engineers try to develop improved biocatalysts, these reactor configurations can be used for screening various biocatalyst alternatives. These studies will help in reducing the potentially significant time needed in developing a biocatalytic process and making it economically feasible. For expensive biocatalysts, it is essential to reuse or maintain the activity of the enzyme by procedures such as immobilization [116]. These experiments can be easily tested using different microreactor configurations thus screening various process alternatives. Clearly, protein engineers and process engineers need to work together to develop an economically feasible industrial scale biocatalytic process. For more promising reactor configurations, sensitivity analyses of various process conditions can be tested. Then, different engineering tools can be used for faster decision making [8]. In order to build the reactor configurations for industrial purposes, it is crucial to be able to reproduce the results from microscale into industrial scale. Although it is challenging to obtain the selectivity of a microreactor configuration in a conventional reactor, the data acquired at microscale can be used as a guide to understand the process limitations during scale-up. The economic feasibility of the process has to be re-evaluated after scale-up but these microscale test procedures are expected to significantly reduce the number of process alternatives that need to be screened. Thus, it is expected that this will also reduce the process development times for scale-up. 
3.5 Conclusions  An essential step to design reactors is gaining more process understanding. There are various tools for gaining more process knowledge and understanding: experiments in lab scale equipment, modelling and simulations. Microreactors can prove to be an effective tool as they can be easily fabricated and tested. It has been demonstrated here that combining microreactor technology and computational fluid dynamics (CFD) can be used for rapidly acquiring process data, the diffusional properties of substrate and product, and understanding process limitations as substrate and product inhibitions. For the case study of biocatalytic transamination, comparing CFD simulations with experimental data, it is shown that the substrate (APH) diffuses considerably slower, up to a factor 1000, compared to the product (MBA). This is vital information in designing reactor configurations. A simple YY channel 
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reactor was designed with 2 inlet streams for combining the enzyme stream and the substrate stream in a laminar parallel flow and separating them at the end of the channel. This reactor configuration is shown to perform better than the traditional well mixed batch reactor for three residence times, 6.6, 30 and 60 min even though the reaction is limited by species transport due to the laminar nature of the flow. This is achieved using less volume of reagents and 6 times the number of experiments can be conducted using the same volume of consumed reagents compared to the batch scale. Further, in order to increase the species transport, the number of contact surfaces were increased in the 8S reactor configuration by splitting each inlet stream into 4 sub-streams and recombining them in an interdigitated flow. The 8S reactor configuration is shown to perform better than the YY channel reactor by increasing the species transport. However, the increase in reaction performance is not proportional to the increase in the number of contact surfaces indicating that the reaction rate is now limited by the substrate and product inhibitions or reaction kinetics, and not the material transport.  Thus the 8S reactor configuration gives us a more fundamental understanding of the process limitations such as substrate and product inhibition. However, the maximum yield that was obtained using the 8S reactor configuration is <10% which is considerably less compared to industrial yields of 50-95% that should be achieved for a process to be economically feasible. Further process techniques and strategies that need to applied in order to increase the yield are discussed in detail in chapter 4.     
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4 Techniques for process intensification 
This chapter gives an introduction to the various process techniques that can be applied for intensification of biocatalytic processes with a focus on how some of these techniques were implemented at microscale.  
4.1 Challenges and techniques in development of a biocatalytic reaction Biocatalytic reactions using hydrolases (Lipases) are widely used and processes implemented in the industry because of their high stability, tolerance to various substrates and products and favourable thermodynamics. However, there are other types of enzymes, such as transferases and keto-reductases, that are less prominent because of their limitations to enzyme stability, activity, substrate and product tolerance and unfavourable thermodynamics. This can be attributed to an ineffective biocatalyst requiring biocatalyst improvement and/or a too low productivity for establishment of an economically viable process, thus requiring efficient process strategies and design (for instance improved reactor design as discussed in chapter 3).  There are two main parts in the development of a biocatalytic process for industrial implementation: biocatalyst development and process development [8]. The biocatalyst development part deals with protein engineering and fermentation technology to improve the biocatalyst and the cost effectiveness of producing it including the optimization of the fermentation process [117, 118]. The process development part deals with engineering solutions to optimize or improve process performance: enzyme stability can be improved by techniques such as immobilization [116, 119] or enzyme cross-linking [120]; substrate intolerance can be overcome by techniques such as in-situ substrate supply (ISSS) or reactor design [121], product and co-product intolerance can be overcome by in-situ product removal (ISPR) [122] and in-situ co-product removal (IScPR) [123] respectively, the thermodynamic equilibrium can be shifted by ISPR and/or IScPR [8] and further integration of one or more of these systems to improve the efficiency of the process. This chapter deals with the process development part using engineering solutions and various process techniques are discussed in detail. Recently there have been many advances in the field of protein engineering including directed evolution, gene synthesis, sequence analysis, bioinformatics tools and computer modelling to fit the biocatalyst to the desired properties such as activity, stability and selectivity [118, 124-129]. However despite these advances in biocatalyst improvement, there is still a considerable need for engineering solutions to be applied for industrial implementation. Constraints such as thermodynamic limitations 
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cannot be addressed by biocatalyst improvement and need engineering solutions. The design of the process should be based on the cost effectiveness of the operation. The biocatalytic process development involves the following steps: biocatalyst improvement; reactor and process design and downstream process design. Changes to the former steps such as obtaining a new strain or enzyme form/variant will affect the later development steps and each of these steps has to be screened for cost effectiveness of operation. Thus there is a need for new systematic process development which includes the protein engineering and process engineering. Many researchers have addressed the systematic methodology for process development of biocatalytic processes [45, 46, 117]. The first step is to set the economic and quality targets from which process targets can be derived and from these further sub-targets can be determined. For instance sub-targets such as fermentation yield and product concentration for downstream processing can be determined from economic and quality targets. 
4.1.1 In-situ substrate supply (ISSS) The controlled substrate supply is needed for maintaining the substrate concentration below its threshold if the substrate has low aqueous solubility or if it is toxic towards the biocatalyst or if it inhibits the activity of the biocatalyst (based on kinetic data). Kim and co-workers [130] have highlighted the importance of substrate supply for effective biocatalysis and described various examples of phase/reactor and substrate delivery configurations. Different methods can be employed such as fed-batch operation or use of an auxiliary phase. Resins or organic solvents can be used as auxiliary phases. The auxiliary phase can be included internally or externally to the reactor. Some techniques for ISSS are highlighted in table 4.1. 
4.1.2 In-situ product removal (ISPR) A technique to overcome the product inhibition of enzyme activity or minimize the product degradation or to shift the thermodynamic equilibrium is to remove the product in-situ. ISPR techniques such as extraction (solvent, membrane, resin), crystallization, precipitation etc., have been increasingly used as a process solution to increase process yields by multiple folds [131-133]. However it is important to identify the most optimal and cost effective way to implement. Implementation of ISPR strategies has been addressed by Woodley and co-workers [122]. The choice of ISPR would depend mostly on the product properties. The implementation would however depend on other parameters such as interaction with other compounds, ease of operation etc. In some cases IScPR is also needed for instance to shift the thermodynamic equilibrium. Often, low product concentrations in the aqueous phase leads to ineffective extraction and thus there is a need to obtain a high product concentration for effective downstream processing [134].   
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Table 4.1 Overview of some techniques reported in the literature for substrate supply 
Process 
technique 
Supply mode Pros cons Ref 
Fed-batch 
Fed over a period of time; Dilution rate determines the concentration in the reactor 
Controlled feeding; can be optimized to maintain high enzyme activity 
Aqueous solubility limitations [135] 
Organic solvent Fed by diffusion of the substrate molecules 
Can be integrated with product removal in a single step; Enzyme membrane reactors can be designed for efficient operation 
Toxicity effects of the organic solvent to the biocatalyst; volatilization [136] 
Ionic liquid Fed by diffusion of the substrate molecules 
Replacement where substrates are sparingly soluble in organic solvents Expensive 
[137, 138] 
Resin Fed by desorption and diffusion 
Can be integrated with product removal in a single step; ease of downstream processing 
Mechanical strength - stirring may damage the resins; Interaction with enzyme may affect its stability 
[139] 
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ISPR using extraction can be performed using organic solvents or synthetic resins. Organic solvents are quite widely used in chemical and pharmaceutical industries. But recently efforts from regulatory authorities have focused on minimization of the use of toxic organic solvents which can be hard to separate from the final product [140]. As such they have been classified based on their environmental impact and operational safety [141]. Another method is to perform solid phase extraction (SPE) using resins. Use of organic solvents brings some extra considerations with respect to approved solvents and downstream processing. On the other hand extraction using resins simplifies the downstream processing as they are inert and easy to isolate. Synthetic resins can be customized to suit the process and product requirements.  Selection methodologies for ISPR can be based on integrating unit operations [142] or physical and chemical properties of products and co-products [143]. The selection criterion should be based on high product selectivity, high dynamic loading capacity, downstream processing and an overall cost analysis.  Some techniques for ISPR are highlighted in table 4.2. 
4.1.3 Enzyme stability and activity Biocatalyst utilization can be increased by increasing the stability of the enzyme through protein engineering or techniques such as immobilization. Truppo and co-workers have achieved the increase in enzyme stability through protein engineering in the industrial process of producing Januvia (sitagliptin) where the transaminase has been engineered to operate in organic solvent [144]. Hickey and co-workers have shown that the thermophilic ϒ-lactamase retained 100% of its initial activity for 6 hrs and 52% after 10 hrs through immobilization [145]. However, the authors have shown that the activity reduced by more than 70% as compared to free enzyme. Thus there is a trade-off to be made between increase in stability and loss of activity (through immobilization) which also needs to be screened for process viability.       
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Table 4.2 Overview of some techniques reported in the literature for product removal  
Process 
technique 
Removal mode Pros cons Ref 
Extraction -Organic solvent Partitioning coefficient 
Solvents with higher partitioning coefficients towards the product can be  selectively identified 
Toxicity effects of the organic solvent to the biocatalyst; volatilization [144] 
Extraction -Ionic liquid Partitioning coefficient Replacement where compounds are sparingly soluble in organic solvents Expensive [137, 138] 
Extraction -Resins 
Adsorption / absorption based on hydrophobicity or ionic charge 
Inert and easy isolation; easier downstream processing; can be customized to be selective to the product 
Loading capacities may be less as compared to organic solvents 
[143, 146] 
Membrane 
Transport across the membrane based on molecular weight, concentration gradient,  hydrophobicity 
Membranes can be custom manufactured to have higher selectiveness to the desired product 
Mechanical strength over pressure gradients; clogging [132] 
Evaporation Volatility of components Isolation of the product in high purity Selective towards products with higher boiling points [147] 
Stripping Volatility of components Product can be isolated by a subsequent step for absorption etc Gas phase selectivity towards the product [131, 148] 
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4.2 Process intensification (PI) in biocatalysis Process performance could be greatly improved by an increased understanding of the relationship between process properties and performance. Pollard and Woodley have stated the importance of developing new methods for improving the efficiency of process development for biocatalysis [149].  Tufvesson and coworkers have stressed that future biocatalytic processes will incorporate PI in order for them to be industrially viable [8]. Moulijn and coworkers have stressed the  importance of PI for biocatalytic reactions as enzymes exhibit high selectivity and a possibility of obtaining higher rates, they provide a basis for intensified processes [150]. The authors have attempted to define PI in relation with process systems engineering (PSE). Grossmann and Westerberg have defined PSE as concerned with improvements of decision making processes for the creation and operation of the chemical supply chain (from the molecules to the plant scale and enterprise level) [151]. Thus PSE has much broader focus on developing systematic procedures for the design, operation and control of process systems ranging from microscale to macroscale including continuous and batch processes while the focus of PI is narrowed on to increasing the efficiency of the individual steps.  
4.2.1 Process metrics for evaluating biocatalytic processes As discussed before, each of the process techniques improves the process performance but also has a cost factor associated with it. It is of high importance to evaluate the cost-effectiveness of a biocatalytic process with or without intensification even during early stages of biocatalyst modifications because it has an impact on the industrial viability of the process. Critical process metrics for each step of the biocatalytic process development are defined to be [8, 46, 152]: yield on substrate; yield on biocatalyst; space-time yield (STY) and product concentration.  The volumetric productivity or space-time yield (STY) is defined as an important intensification criterion for the biocatalytic process as it includes the catalyst activity and stability under reaction conditions. This metric thus includes the substrate supply and product removal efficiency on the enzyme activity together with other parameters like effect of temperature, pH and mixing. This metric thus helps with capital cost calculations for instance to fit into an existing plant etc.  Substrate yield or reaction yield forms a measure of the raw material cost to the economic feasibility of the process. Biocatalyst yield is a measure of the biocatalyst cost contribution. Higher substrate and biocatalyst yields are required to reduce the operating cost of the reactor. However these would further depend on the cost of producing the biocatalyst and the final product cost. Product concentration is a measure of the downstream processing (DSP) costs and thus high product concentrations are required for efficient downstream processing.  
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Threshold values of these metrics for achieving economic viability depend on the industrial sector. For the bulk chemical industry, the product selling costs and thus the process implication costs are lower compared to fine chemical or pharmaceutical products. Thus there is a need for obtaining higher yields and productivity for economic sustainability. These requirements would also further depend on the upstream (fermentation), biocatalyst form, downstream an operational costs etc. Tufvesson and co-workers [45] have approximated the threshold values for the defined process metrics for scale-up of biocatalytic process for different industrial sectors which can be used as guidelines during process development.  Tufvesson and co-workers have also introduced a graphical tool, the windows of operation, to quickly evaluate and estimate the constraints arising from biological, reaction and economic limitations that govern the process [153]. Such a tool can be very useful during early stage process development to identify the feasibility window. Lima-Ramos and co-workers [117] have further extended the concept to add various constraints to obtain the threshold values for variables added to obtain the operational space for desired performance. To identify the windows of operation for each biocatalyst would require making experiments by changing all the process variables using design of experiments. Modularity of experiments can ease this process significantly. Leuchs and co-workers have increased the biocatalyst yield by using a cascade of enzyme membrane reactors with co-product degradation and integrated with solid-phase product extraction, and achieved a high space-time yield (STY) of 1.42 gP/L.h [154]. The authors have later exploited modelling and simulation tools for optimization of such a complex process and highlighted that improvements by reaction engineering may be more cost and time effective as compared to biocatalyst modifications to suit the process constraints [155]. Examples of some process techniques applied for different biocatalytic reactions are summarized in Table 4.3 along with the process intensification achieved.  
Techniques for process intensification 
41  
Table 4.3 Process intensification examples achieved through various process techniques 
Biocatalyst 
Enzyme 
form 
Reaction 
schema 
Limitations 
Process techniques 
employed 
Intensification achieved Ref 
Candida tenuis xylose reductase (CtXR); 
Candida boidinii formate dehydrogenase (for cofactor regeneration) 
WC Reduction of o-chloro-acetophenone 
Low substrate solubility; Substrate inhibition; Product inhibition 
ISSS using auxiliary phase (resins) and Fed-batch; ISPR using auxiliary phase (resins) 
Efficacy of the process was enhanced by more than 2 orders of magnitude [156] 
Alcohol dehydrogenase from Lactobacillus 
brevis WC 
Reduction of 2,5-hexanedione 
Low substrate solubility; Unfavourable thermodynamics 
IScPR - Extraction of the co-product by pervaporation and stripping (using ionic liquids) 
Conversion % (substrate yield) increased from 50% to >90% (using either pervaporation or stripping) 
[148] 
Styrene monooxygenase from 
Pseudomonous sp. strain VLB120 
WC Synthesis of (S)-styrene oxide from styrene 
Low product concentration; Low productivity for economic industrial viability 
Implementation of bi-phasic system (organic phase) for substrate delivery 
Product concentration increased from 36.7 g/Lorg to 72.6 g/Lorg; cost of 1 kg of styrene oxide reduced from $16.9 to $10.2 
[157] 
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Alcohol dehydrogenase from Lactobacillus 
brevis (LbADH) WC 
Enantioselective reduction of aliphatic ketones (D-glucose) 
Low aqueous solubility of substrates and products; Low enzyme utilization; Unfavourable thermodynamic equilibrium 
Using Ionic liquids for increasing the solubility of substrates and co-products; Biocatalyst yield increased by using ultrafiltration in an enzyme membrane reactor; Two enzyme reactors added as cascade and further extraction using resins was included 
The overall cost base was reduced by 65%; Environmental assessment parameters: E-factor (kgwaste/kgproduct) reduced from 132 to 17; PMI (kgsubstrate/kgproduct) reduced from 133 to 18; STY of 1.417 gP/L h was achieved 
[154, 155] 
Aminotransferase from Pseudomonas 
stutzeri Immobilized 
Synthesis of enantiomerically pure D-phenylglycine 
Unfavourable thermodynamic equilibrium; Substrate inhibition 
Controlled release of substrate (using resins); Precipitation of the product; Co-product adsorbed back into the resin 
Four-fold increase in product concentration to 10.25 g/L [158] 
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Cyclohexanone monooxygenase from Acinetobacter 
calcoaceticus WC 
Baeyer-Villiger oxidation process (oxidation of bicyclo[3.2.0] –hept-2-en-6-one) 
Oxygen supply; Product inhibition; Biocatalyst stability 
Increased the maximum oxygen transfer rate High product concentrations were achieved [159, 160] 
Cyclohexanone monooxygenase from Acinetobacter 
calcoaceticus WC 
Baeyer-Villiger oxidation of rac-bicyclo[3.2.0]hept-2-en-6-one 
Oxygen supply; Substrate and Product inhibitions; Biocatalyst stability 
“two-in-one” in situ substrate feeding and product removal concept (using adsorbent resin); Bubble column reactor design for oxygen supply 
Achieved high volumetric productivity or STY of 1 gP/L.h; High substrate yield of 84% achieved 
[161] 
Pseudomonas 
putida MC2 WC 
microbial biotransfor-mation of 3-methylcatechol from toluene 
Product inhibition; Biocatalyst toxicity to organic solvents (in a Biphasic system) 
Solid liquid two-phase partitioning bioreactor for product removal (using polymer beads or sheets); Polymeric beads as external loop packed bed reactor or polymer sheets inside the bioreactor 
Increased product concentration to 4 g/L [162] 
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Rhodococcus 
erythropolis DCL14 WC 
microbial biotransfor-mation of (−)-
trans-carveol to (R)-(−)-carvone 
Substrate and Product inhibition; Use of organic solvents resulted in formation of severe emulsions because of the hydrophobic nature of the microorganism 
Solid liquid two-phase partitioning bioreactor for substrate delivery and product sink (using single or mixture of polymer beads) 
Achieved 7 times higher substrate loading; Enormously enhanced operability relative to the two liquid phase configuration; Highest performance achieved through using mixture of polymer beads (internal for substrate delivery and external for product removal) 
[163] 
Kluyveromyces 
marxianus WC 
microbial biotransfor-mation of L-phenylalanine  to  2-phenylethanol 
Low product concentration; Low productivity 
Solid liquid two-phase partitioning bioreactor for in-situ product removal (using polymer resins) 
Product concentration increased from 1.4 g/L in a single phase system to 13.7 g/L achieved in batch operational mode and 20.4 g/L in semi-continuous operational mode with productivities (STY) of 0.38 and 0.43 gP/L h respectively 
[164] 
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Pichia pastoris WC 
microbial biotransfor-mation of benzyl alcohol to benzaldehyde 
Substrate and product inhibition; Low aqueous product solubility; Biocatalyst toxicity to organic solvents (in a Biphasic system) 
Solid liquid two-phase partitioning bioreactor for substrate delivery and product sink 
Overall mass of benzaldehyde increased from 4.89 g to 15.0 g; Molar substrate yield (molproduct / molsubstrate)  increased from 0.31 to 0.99 while Volumetric productivity (STY) remained almost the same at 0.07 gP/L h 
[165] 
Candida utilis WC 
microbial biotransfor-mation of benzaldehyde and glucose to L-phenylacetylcarbinol (PAC) 
Substrate, product and by-product toxicity; Biocatalyst toxicity to organic solvents (in a Biphasic system) 
Solid liquid two-phase partitioning bioreactor for substrate delivery and product sink 
Product concentration of 11 g/L achieved, 1.9 fold increase over the single phase system; Substrate concentration reduced to 4.5 g/L, 1.6 fold reduction over the single phase system; Volumetric productivity (STY) of 0.85 gP/L h achieved, 1.2 fold increase over the single phase system 
[166] 
Clostridium 
acetobutylicum 
P262 
Immobilized 
Acetone-Butanol-Ethanol fermentation using lactose substrate 
End-product inhibition 
Immobilization of cells onto a packed bed column; Product removal by pervaporation 
Productivity increased 20 times as compared to batch system [167] 
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4.3 Microreactor configurations to process solutions The feasibility of each process technique using predefined process metrics needs to be characterized during process development of a specific biocatalytic process. The challenge here is to simultaneously screen for all the properties – multifunctional screening [8]. Using an integrated microsystem as a screening device, different enzymes (forms and variants), different donors and acceptors can be screened together with substrate supply and product removal – multifunctional screening, saving a lot of time and amount of enzymes. Each process technique can be built as an individual module to be integrated with the reactor in order to rapidly test, collect data, analyse and compare performances. The degree of integration of functionalities requires process optimization. Some important parameters such as substrate feeding strategy, enzyme concentration, stability, product removal rate need to be optimized in order to achieve the goals for industrial viability. Thus this becomes a multivariate       non-linear optimization problem for productivity and stability.  Truppo and Turner have developed a convenient and rapid microscale process development strategy for transamination reactions [67]. The authors have demonstrated the optimization of various process parameters at microscale and a direct scale-up from microscale to process scale with no further modifications of the reaction conditions identified at microscale. Liese and co-workers have integrated enzyme microreactors with continuous extraction for enzymatic resolution of 1-phenyl-1,2-ethanediol by enantio-selective oxidation [168]. Shin and co-workers have also successfully used the enzyme membrane reactor with continuous product extraction for kinetic resolution of chiral amines using ω-transaminase [169]. Shin and co-workers have later also shown for kinetic resolution of chiral amines 
using ω-transaminase, that an enzyme packed bed reactor with integrated continuous product extraction performs better than the enzyme-membrane reactors [170]. However, the economic feasibility of both these processes needs to be evaluated for industrial implementation. But this shows that during process development, each process technique needs to be evaluated and compared for its performance. Table 4.4 summarizes the customized modules at microscale that can be built for different process techniques.   
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Table 4.4 Overview of some customized modules that can be built for applying process techniques 
Process technique 
Customized modules at 
microscale / Microfluidics 
Pros Cons Ref 
Single phase for ISSS and ISPR 
Y, ψ junction straight channel microreactor; combining and splitting of streams in laminar parallel flow 
Integrated ISSS and ISPR; Easy to fabricate and operate 
Diffusional limitations; limitations to the length of the microchannel for longer residence times and higher conversions 
[171] 
Solvent (2-phase system) for ISSS and ISPR 
Y, ψ junction straight channel microreactor; combining and splitting of streams in laminar parallel flow 
Integrated ISSS and ISPR; Easy to fabricate and operate 
Diffusional limitations; Biocatalyst deactivation in contact with the auxiliary phase 
[172] 
Solvent (2-phase system) for ISSS and ISPR 
Y, ψ junction straight or meandering channel microreactor; segmented or slug flow inside a microchannel 
Integrated ISSS and ISPR; Slug size can be controlled for effective mass transfer 
Diffusional limitations;  Biocatalyst deactivation in contact with the auxiliary phase 
[173, 174] 
Fed-batch for ISSS Meandering or straight channel with multiple inputs; Intermittent mixing of streams High product concentrations can be achieved Kinetic modelling is required to employ feeding strategy [91] 
Membrane for ISPR Continuous membrane microbioreactor Isolation of the enzyme from the auxiliary phase 
Mass transfer limitations; membrane sensitivity to pressure build-up; membrane clogging [175] 
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Process technique 
Customized modules at 
microscale / Microfluidics 
Pros Cons Ref 
Feeding electrons into the active site of redox enzymes by electro chemistry as alternative to using co-enzymes for co-factor recycling 
Bioelectrocatalytic biphasic microfluidic system 
Coenzyme independent; The small dimensions of microreactors are aptly suitable for electrochemistry because of the relative shorter distances between anode and cathode; able to obtain a high surface area of electrodes 
Smaller quantities of product, can be synthesised [176] 
Substrate is supplied as plugs inside a capillary which moves in and out of the enzyme plugs based on their electrophoretic mobilities 
Electrophoresis capillary as microreactor 
With different electrophoretic mobilities, the relative order and the time of injection of substrate and the enzyme can be used to ensure contact; can be modified to have plugs of enzyme and continuous stream of reactants 
Average mobility of the enzyme may change after binding to the substrate [177] 
Immobilization of the enzyme - coated as surface layer attached to microchannel walls for increase in stability 
Coated wall microreactor Increase in enzyme stability; can be operated as continuous reactor;  Multiple linear flow channels can be achieved 
Decrease in activity; Mass transfer limitations [178] 
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Process technique 
Customized modules at 
microscale / Microfluidics 
Pros Cons Ref Immobilization on to resins for increasing the enzyme stability Microscale packed bed reactors 
Increase in enzyme stability; can be operated as continuous reactor Decrease in activity; Mass transfer limitations [64] Immobilization on to nanosprings for increasing the enzyme stability Microscale packed bed reactors 
Nano springs provide high surface area with good permeability and mechanical stability 
Decreased conversion at lower permeabilities [179] 
Gas-liquid-solid three phase biotransformation; Gas-phase supply of substrate (O2); Enzyme immobilization for increasing the stability of enzyme 
Honeycomb monolith microbioreactor Increase in enzyme stability; can be operated as continuous reactor 
Gas-liquid and liquid-solid mass transfer limitations; decrease in enzyme activity [180] 
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5 Microscale packed bed columns and CFD as 
screening and design tools for solid phase 
extraction 
As discussed in chapter 4, solid phase extraction (SPE) using resins is an attractive ISPR option alternative to using toxic organic solvents and will also further ease the downstream processing. This chapter deals with screening of resins for SPE using microscale packed bed columns and CFD as screening and design tools. 
5.1 Introduction:  Synthetic resins are used as attractive options to support catalysts for catalytic reactions, for extraction, immobilization of enzymes etc. as they are readily synthesized, inert and offer easy handling, recycling and removal from reaction mixtures through filtration. The technology as such is widely used in the chemical and pharmaceutical industry. ISPR using resins, as described by Woodley and co-workers [122], can be carried out internally or externally to the reactor with direct or indirect contact to the enzymes. The simplest configuration is to directly suspend the resins into the reactor for internal direct contact. This configuration may lead to a decrease in biocatalyst activity due to direct contact with the resins. External contact can be achieved by loading the resins in a packed column configuration. Indirect contact can be realized using a membrane to separate the cells from the resins or by immobilizing the enzymes on different solid supports (resins, nano-springs etc) which will ease the retaining of the biocatalyst and product isolation. Integration of the membrane to separate the cells can be internal or external to the reactor. Lima [181] has shown a significant increase in biocatalyst yield and product concentration by operating the ISPR in an external packed column configuration with indirect contact to the biocatalyst. This mode of operation has many advantages as: easy product/biocatalyst separation, easy re-using of the biocatalyst and resins, resins are protected from damage; product can be removed without affecting the biocatalyst and mass transfer is enhanced through the use of the packed column configuration. As such it is of interest to screen the performance of various resins for ISPR in a packed column configuration and evaluate the performance achieved under operational conditions.   
Microscale packed bed columns and CFD as screening and design tools for solid phase extraction  
51  
Microscale devices can be used for developing modules such as ISPR which can be effectively used for screening, design and development. Process configurations can be built by integrating such modules developed at microscale. The modularity allows for testing of various process configurations before making a full scale process design, and as such increase the efficiency of screening and process development. Microscale packed bed reactors (µ-PBR), due to improved heat and mass transfer efficiency, can be used as effective tools to screen and characterize various resins under operational conditions. Losey and co-workers reported an increase in mass transfer by more than 2 orders of magnitude for cyclohexene hydrogenation using an activated carbon catalyst in a µ-PBR, compared to its macro scale counterpart [182]. Recently many have investigated and reported improved performance in micro-scale packed bed reactors [183-185]. Andrew and co-workers have reported a more than 3 times increase in productivity compared to batch reaction using a solid supported catalyst in a µ-PBR [183]. Minjing and co-workers have used µ-PBRs for parametric process optimization such as bead size, residence time, temperature, concentration and molar ratios of reactants [184]. Andrej and co-workers have demonstrated the integration of conversion and separation in a µ-PBR for improved process performance [186]. For a lipase based biocatalytic flow process in a packed bed reactor using Novozym 435, Dencic and co-workers have observed that the reaction rate is strongly influenced by the external and intra-particle transport limitations [187].  In this work, a method is proposed for systematic investigation and screening of resins using µ-PBR and CFD as tools (Fig 5.1). The µ-PBR is used to investigate the effect of flow rates on the adsorption efficiency. An integrated CFD model was developed combining the fluid dynamics with mass transfer and adsorption/desorption kinetics. The model is used to estimate the particle permeability and diffusivities, perform sensitivity analysis of parameters and further guide the design of a packed bed column. 
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 Fig 5.1: Proposed workflow for systematic screening of resins for SPE in a packed bed format 
5.2 Materials and methods: 
5.2.1 Case study As a case study, it is intended to screen resins for the extraction of MBA (Fig 3.1). Commercial resins have been identified to study the extraction of MBA and are listed in table 5.1. The ion-exchange resins have been obtained from Purolite® (PA, USA). The hydrophobic resin (Lewatit-AF5) was procured from Sigma-Aldrich. These resins have been used in industry mainly for purification of water, adsorption of organic compounds etc. but to my knowledge never used for ISPR in ω-transaminase catalysed reactions. Thus it is intended to perform a detailed study of the resins, screening for high capacity and selectivity and faster kinetics (faster sorption rates).     
 
Flow rates 
1) Resin  screening 
2) Sorption isotherm 
3) µ-PBR  dynamics 
4) CFD  simulations 
Isotherm parameters 
Distribution coefficient 
Dynamic loading capacity 
Breakthrough curves 
Sensitivity  analysis 
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Particle size, Surface area 
Hydrophobic or Ionic 
Hydrodynamics 
Particle permeability 
Pore and surface diffusivities 
Pore diameter and volume 
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Table 5.1: Resins information 
Resin Type Size (µm) 
Bulk 
density 
(g/L) 
Pore 
volume 
(cm3/g) 
Surface 
area 
(m2/g) 
Pore 
diamet
er 
(nm) 
γ , Porosity   
pore volume 
/total 
volume 
Lewatit 
AF5 
Hydrophobic 400-800 550-650 0.15 1200 8 0.09 
C150 
Strong cation exchange Na+ form 300-1200 785-825 0.23-0.26 29-37 34-36 0.26-0.30 
C104 
plus 
Weak cation exchange H+ form 300-1600 740-780 NA NA NA NA 
C115E 
Weak cation exchange H+ form 300-1600 660-705 NA NA NA NA  
5.2.2 Analytical method  A reverse phase HPLC method (Ultimate 3000 HPLC equipped with UV detector and photodiode array detector) was used for analysis of MBA. A Gemini-NX® 3 µm C18 (2) 110 A (100x2 mm) column (Phenomenex) was used to detect the compound using a flow of aqueous 25 mM Ammonium bicarbonate (pH 11) and acetonitrile (99.8%) at a flow rate of 0.5 mL/min. The compound was quantified at a wavelength of 260 nm with retention time of 1.223 minutes. 
5.3 Experiments 
5.3.1 Batch experiments – resin screening  Batch experiments were performed by preparing 13 vials of 4 ml volume, each filled with 1 ml of 200 mM MBA. The vials are loaded into the thermal shaker at 300 rpm at 30 oC. At time t=0, 30 mg of resin are added to the vial and samples are taken from different vials at regular time intervals in order to obtain the loading and the kinetics of the sorption process (conc. vs time). Experiments are repeated for all the resins from table 5.1 and the results are plotted and discussed in section 5.5.1. 
Microscale packed bed columns and CFD as screening and design tools for solid phase extraction  
54  
5.3.2 Batch experiments – adsorption isotherm Batch experiments were performed in 4 ml vials containing 2 ml of MBA at different concentrations. The vials are loaded into the thermal shaker at 300 rpm at 30 oC. 12.5 mg of resin are added to the vials. 3 samples were obtained after 1 hour and analysed (from initial batch experiments it was observed that equilibrium was reached in an hour). Experiments were performed with different initial concentrations of MBA, 150 mM, 125 mM, 75 mM, 50 mM, 25 mM and 5 mM. The results are plotted in section 5.5.2 along with the standard deviation (error bars).  
5.3.3 µ-PBR experimental set-up µ-PBRs were obtained from Microfluidic-ChipShop A/S as a part of the European seventh framework project BIOINTENSE. Resins are sieved in order to obtain a uniform size distribution of 0.6 – 0.7 mm particles. Resins are packed randomly inside the µ-PBR while trying to maximize the resin loading by manual shaking of the column (Fig 5.2). A resin loading of about 13.2 mg is achieved which is measured by comparing the weight of the empty column and the filled column.  The concentration is measured at the inlet (
0A
C ) and at the outlet ( AC ) of the µ-PBR. The normalized concentration (
0A A
C C ) is plotted over time in order to obtain the breakthrough curves. From a breakthrough experiment, the adsorbent capacity can be calculated and varies accordingly with changing initial concentration and operating conditions (flow rate, temperature etc). The columns are initially flushed with water for 15 min in order to wet the resins. Then at time t=0, the flow is shifted to MBA (~conc. of 190 mM). Samples were collected directly into prefilled vials for a specified period of time, while water was added up to the required dilution. Samples were filtered before further analysis. Experiments were repeated at different flow rates and the breakthrough curves are plotted in section 5.5.3. 
  Fig 5.2: µ-PBR - volume of 32.9 µl – with 2 inlets and 2 outlets; packed with Lewatit AF5 resins                    – 13.2 mg 
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5.4 Results and discussion 
5.4.1 Batch experiments – resin screening All the resins listed in table 5.1 were screened and the dynamic binding capacity is plotted as a function of time in Fig 5.3. The adsorbed amounts are summarized in table 5.2 and it can be seen that the hydrophobic resin, AF5, has 6 times more loading capacity than the strong cation exchange resin C150 Na+ form. Both weak cation exchange resins, C104plus H+ form and C115E H+ form, have 1.1 and 1.4 times higher loading capacities respectively, compared to the hydrophobic resin. However, from figure 5.3 (zoom area), it can be seen that the hydrophobic resin has the highest initial rate (for the first 1000 s, it has adsorbed more MBA than the other resins). This can be attributed to the fact that the hydrophobic resin has a large surface area (Table 5.1). Thus it is more promising to use the hydrophobic resin with faster rate under continuous process conditions such as a packed bed column. Moreover, extraction of the product from the resin is easier compared to that of ion exchange resins. Thus it is intended to use this resin for further analyses using µ-PBR.  
 Fig 5.3: Comparison - dynamic loading capacity - C150E, C104plus and Lewatit AF5   
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Table 5.2: Amount of MBA adsorbed to different resins in batch experiments  
Resin 
Amount 
absorbed 
mmol/L 
Weight (mg) 
Amount 
absorbed 
mmol/g 
AF5 (24 hrs) 105.4385 30.6 3.45 
C150 (24 hrs) 18.039 30.6 0.59 
C104plus (24 hrs) 150.663 30.6 4.92 
C115E (after 3 hrs) 113.855 30.8 3.7  Further experiments were performed maintaining the same surface area of the resins, thus comparing the adsorption capacity to the surface area. Based on a constant surface area, C150 has 1.8 times higher loading as compared with AF5. This gives us an indication of the effect of surface areas on the loading capacities of resins. Please refer to Appendix 2a for details. Experiments were also performed to check for the maximal loading by varying the resin weight and the results are presented in table 5.3, which shows that higher loading capacity (mmol/g) can be achieved by adding more resin. The observed non-linearity can be attributed to the non-uniform penetration of the particle, higher loading at outer surface compared to the inner core.  This gives us an indication of the mass transfer limitations because of less particle penetration occurring in a batch set-up. Table 5.3: Amount adsorbed – varying resin loading 
Resin 
weight (mg) 
Adsorbed 
amount (mM) 
Loading  
(mmol/g) 10.5 25 2.38 25 86 3.44 50 168 3.36 
5.4.2 Adsorption isotherm The distribution coefficient of the adsorbate between the phases is important to determine the aqueous product concentration that can be obtained based on the resin loading at equilibrium. The 
Microscale packed bed columns and CFD as screening and design tools for solid phase extraction  
57  
adsorbate to resin ratio is called the phase ratio and plays an important role in determining the equilibrium aqueous concentration of the adsorbate. The rate of removal increases with the increase in resin loading. The phase ratio also plays an important role in determining the type of the reactor to be used [188]. For the resin to be the best candidate, it has to display a favourable adsorption isotherm to provide evidence of its affinity to the adsorbate. The adsorption isotherm of the Lewatit AF5 resin is measured by varying concentrations of the adsorbate to a fixed amount of the resin. The results are plotted in Fig 5.4.  The sorption data can be best modelled by using a Langmuir adsorption isotherm, as shown in equation 5.1, with the R2 value of 0.985 (Fig 5.4 – dotted line). It is assumed that the resin is in local thermodynamic equilibrium and as such this model can be applied.   
max
1
A eq
eq
C K C
q
K C
⋅ ⋅
=
+ ⋅
                     [5.1] 
Where q is the resin loading (mmol/g), maxAC (mmol/g) is the maximum adsorption capacity, eqC is the concentration in the fluid at the thermodynamic equilibrium and K is the distribution coefficient. 
 Fig 5.4: Adsorption isotherm The distribution coefficient of MBA between the resin and the aqueous phase ( K ) is determined to be 0.515 L/g and the maximum adsorption capacity ( maxAC ) is calculated to be 3.02 mmol/g. Shin and co-workers have studied the partitioning of MBA in cyclohexanone (organic solvent) and obtained an overall partitioning coefficient of 0.21 [189]. Thus, as described by Straathof and co-workers [190], higher distribution coefficients can be obtained using resins as compared to organic solvents. 
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5.4.3 µ-PBR Results The performance of the resins under continuous flow conditions in a column bed has to be evaluated to determine the breakpoint and the shape of the breakthrough curves. The break point determines the volume of the stream that can be treated with the bed before the breakpoint is reached and thus the extraction efficiency of the bed. Such experiments at different inlet flow rates and feed concentrations can be performed in a µ-PBR for determining the efficiency of the bed. Here, continuous experiments at different flow rates were performed in a µ-PBR packed tightly with the Lewatit AF5 resins and the results are plotted in Fig 5.5. These experiments will be used to determine the dynamic loading capacity at different flow rates.   
 Fig 5.5: Adsorption of MBA achieved at different flow rates The adsorbed amount is indicated by the area between the y-axis and the breakthrough curve for the time t∆ . The Trapz method in the software tool, MatLab, is used to calculate this area. Please refer to appendix 2b for details. From the adsorbed area the amount adsorbed ( adsn ) is calculated, equation 5.2, and the results are presented in table 5.4. The feed concentration of MBA ( 0AC ) is 190 mM, the resin loading is 13.2 mg and Q is the feed flow rate. 
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Table 5.4: Amount adsorbed, adsn , at different flow rates 
Flow rate, 
Q  (µL/s) 
adsn  
(mmol/g) 
1 2.655574 
0.73099 2.847735 
0.52033 3.828748 
0.2604 3.992997 The breakthrough curves (Fig 5.5) show that for a feed concentration of 190 mM, a flow rate of 0.26 µL/s, and resin loading of 13.2 mg the breakthrough happens after 180s. Thus the resins will not be able to effectively extract the product after 180s. This indicates that a much higher resin loading is needed to effectively extract the product for longer times for the given feed concentration. The steeper breakthrough curves indicate a smaller adsorption zone inside the packed column (the active area of adsorption inside the column) and faster kinetics. The gradual inclination in the breakthrough curves indicates a larger adsorption zone and slower kinetics. However the trajectory of the breakthrough curve, the dynamic binding capacity also depends on the hydrodynamics, packing intensity and kinetics. The results show that higher loading was achieved at lower flow rates (Table 5.4) but steeper breakthrough curves were obtained at higher flow rates. This gives an indication of the effect of hydrodynamics and mass transfer on the dynamic loading capacity. At lower flow rates the adsorbate has a higher residence time in the µ-PBR and thus achieving higher particle penetration through diffusion into the core of the resin and thus achieving higher loading. However the breakthrough curve is less steep (Fig 5.5) indicating a larger adsorption zone. This can be attributed to the packing intensity (large void volumes) inside the packed column. Using smaller particle sizes (lesser void spaces), steeper breakthrough curves can be achieved but energy efficiency of the process decreases as the pressure drop increases significantly. The Darcy’s law for laminar flow expresses that the column pressure drop increases to the square of the particle diameter. In order to achieve steeper breakthrough curves while maximizing the loading and energy efficiency, the effective diffusivity to particle size ratio needs to optimized. Pinelo and co-workers have observed higher yields when the effective diffusivity/particle size ratio was higher for solid phase extraction of antioxidants from grape by-products [191]. Hui and co workers have also observed that for monoclonal antibody purification using resin particles in a packed column, the dynamic binding capacity increases at lower flow rates [192]. Experiments were also performed to evaluate the dynamic desorption or extraction efficiency of these resins. Extraction of the adsorbate was achieved much faster compared to the adsorption rate (Appendix 2c). 
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5.5 Mass-transfer modelling In order to effectively screen and characterize the resins for SPE in a packed column configuration, it is important to understand the mass transfer phenomena under operating conditions (dynamic binding capacity). As described by Miyabe and co-workers [193], mass transfer in the fluid phase happens by axial dispersion and the transport of mass is from the fluid phase to the stationary particle. Chemical species are transported from the fluid that is located in between the particles to the fluid in the particle pores. Mass transfer inside the porous particle happens by intraparticle diffusion which can be described by two models: a) the surface diffusion model; and, b) the pore diffusion model (Fig 5.6). The surface diffusion model assumes that the adsorbate adsorbed to the stationary phase is free to migrate along the solid surface. The driving force for the surface diffusion model is the concentration gradient in the adsorbed phase. In the pore diffusion model, it is assumed that the intraparticle mass transfer occurs by diffusion in liquid-filled pores (pore volume) with a driving force expressed in terms of the pore fluid concentration gradient. The adsorbant is assumed to be in equilibrium with that in the pore fluid at each radial position in the particle. Pore diffusion inside the particle is dominated by molecular diffusivity, pore size and tortuosity. The surface diffusional flux contributes, in parallel with the pore diffusional flux, to the total diffusional flux. In high performance liquid chromatographic systems, Miyabe and co-workers have estimated that the majority of the particle migration occurs by surface diffusion [193-195].  A sensitivity analysis should be performed to determine which parameters have the greatest impact on the dynamic binding capacity. The prediction of the breakthrough point and dynamic binding capacity can result in significant savings in process development time and also save a lot of experimentation time and effort. Model predictions can be used to determine if the resin will have the highest loading capacities over a range of operating conditions (flow rates). Modelling can be further used to identify critical process parameters and support process design and development. 
Pore surface
Pore surface
Pore diffusion
Adsorprtion Surface diffusion
 Fig 5.6:Illustration of fluid filled pores – surface and pore diffusion 
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Modelling of the mass transfer and adsorption through porous adsorbent has been investigated by many researchers to gain more process understanding [196-198]. Kaltenbrunner et al. have reported physical models for mass transfer and adsorption in porous adsorbent [196]. They have stressed that the adsorption and separation processes in a column are complex and vary with both column position and time. Plazl and co-workers have summarized different mathematical models available in the literature for mass transfer in porous media [197]. The authors have identified the values of pore and surface diffusivities by retrofitting model simulations with experimental data. Ayben and co-workers have estimated the pore and surface diffusivities, using empirical equations, for uranium adsorption on amberlite IR-118H resin [199]. Another approach is to use a local thermodynamic equilibrium to model adsorption in porous spherical particles [198]. Surface diffusivities were estimated by Valiullin and co-workers using nuclear magnetic resonance methods [200]. However, in the present work done, it is attempted to use CFD as a tool to model the mass transfer phenomenon, perform a sensitivity analysis and further predict the pore and surface diffusivities.  
5.6 CFD modelling Recently there has been increasing interest in linking engineering models with rigorous simulation tools, with significant improvement in computational resources and tools. CFD provides an innovative approach to model and analyse the local flow and the effect of local parameters. However, earlier investigations of flow in porous media packed beds using CFD provided mainly bulk information such as pressure drop correlations [201]. CFD has been increasingly reported in the recent years in packed bed flow modelling of hydrodynamics and transport properties [202-209]. CFD has been shown to be a useful tool for predicting the flow pattern, temperature prediction, flow velocity and absorption rate [206]. Kloker and co-workers have stressed that physical models usually used mass transfer coefficients, which were determined experimentally, to describe the processes but the mass transfer actually strongly depends on the flow around the particle [205]. Using CFD, more process knowledge can be gained about hydrodynamics and mass transfer in the packed beds. Kloker et al. [205] have shown for a packed column, with a regular arrangement of spherical particles, that the particle trailing zones before the next particle overlap, thus forming stationary zones, and momentum and mass transfer between these zones is limited. They have then reduced the computational domain to fewer particles (wall effects were not included). Magnico has shown that, in a packed column with random sphere packing, particle tracking revealed the existence of a second boundary layer all along the particles in contact with the reactor wall and mass transfer between the two regions is controlled by a diffusive mechanism at low Reynolds numbers [203]. He confirmed that the layers found at low Reynolds numbers tend to disappear at high Reynolds numbers. Both authors have modelled the 
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particles as solid, allowing the no-slip surface flow boundary condition to be used at the solid-fluid interface. However, these results cannot be directly translated to µ-scale systems. Increased mass transfer (loading) in micro-systems strongly indicates the effect of local hydrodynamics on the adsorption rate. For a micro-packed bed column such local effects can be captured by CFD simulations which can give more insight into phenomena such as near wall effects etc. 
5.6.1 Miniaturized model  CFD simulations of the packed bed reactors are generally modelled under the assumption that the intraparticle flow field is symmetric and thus the computational domain is reduced to a small part of the column. However, Dixon and co-workers have shown that this approach is only valid if the reactor has a high tube-to-particle diameter ratio [210]. They have furthermore shown that the assumption of symmetry holds for particles away from the tube wall, but particles placed near the tube wall show significant deviations. Thus in order to better estimate the effect of flow field on the dynamic binding capacity, in the present work it is intended to make a miniaturized system, a tube with 14 resin particles (Fig 5.7). Resins are sieved in order to obtain a uniform size distribution of the particles (0.6 – 0.7 mm diameter particles). A tube with an internal diameter, ID, of 1 mm and 8.5 mm length was filled with 14 resin particles in a random packing. The resin loading weight is measured to be 1.315 mg. The set-up is initially flushed with water for 15 min in order to wet the resins at a flow rate of 0.2604 µL/s. Samples are collected every 10 sec into prefilled vials with 100 µL of water for an overall residence time of 500 sec. The Re is less than 1 indicating a laminar flow regime.  
 Fig 5.7: Tube (1mm ID and 8.5mm in length) with resin particles 
5.6.2 CFD model  The CFD model of was built, simulated and analyzed using the software Ansys CFX 12.1 (ANSYS, Inc.). The geometry was first constructed in the software Solid Works and exported to ICEM (ANSYS, Inc.) for meshing and later exported to CFX for model set-up, simulation and post processing. An unstructured mesh was generated using ICEM’s automatic mesh generation tool which created a fine mesh around the particle and wall contact points. The finer the mesh size or the higher the number of elements, the more precise are the numerical calculations. The mesh sizes were determined by making a grid independent study of the steady state simulations. The particles (spheres) were modified around the problematic contact points for better quality meshing. The mesh was further refined using 
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quality metrics available in ICEM until the criterion is satisfied (Quality value > 0.2) (Fig 5.8). The geometry was meshed with 37053 elements containing 5803 nodes. Owing to the huge surface area to volume ratio of these resins, computational time increases drastically on refining of the mesh size.  The flow rates used are sufficiently low to maintain a laminar flow through the fluid and porous domains. The resin particles are defined as a porous domain (full porous model) in CFX [211]. The particle porosity is defined as the ratio of the volume available to the flow and the physical volume. The surface area and porosity values of the resins are obtained from table 5.1. The flow in the porous domain is modelled using an isotropic loss model instead of discretely modelling all the individual passages within the particle, which would be impossible. Thus the amount of liquid flow though the pores is modelled as porous particle permeability (isotropic) to the liquid flow through the domain. This is governed by Darcy’s law which yields as a result that the flow depends on permeability of the resin, cross sectional area to flow, fluid viscosity, and pressure drop along the length of the packed bed. The full porous model in CFX accounts for momentum loss through resistance loss coefficients which, for all the simulations considered here is kept constant. As discussed before, the intraparticle mass transfer is modelled by defining pore and surface diffusivities. The mass transfer from the fluid phase to the surface is dominated by the kinetics of adsorption and desorption, defined by the kinetic model in section 5.6.3. The governing equations for fluid flow in fluid and porous domains were solved using the solver capabilities in Ansys CFX  [211]. For the detailed model equations please refer to Appendix 2d.  The inlet is defined as the velocity inlet boundary condition while the outlet is defined as an opening. The internal face of the tube is defined as a wall with no slip boundary condition.  The estimated aqueous diffusion coefficient of MBA (chapter 3) was used for the simulations. Dixon and co-workers [210] have run the steady state simulations first to determine the initial flow field with boundary conditions, which was then used to perform transient simulations for species and energy transport. They have shown that the changes to the flow field were minor. A similar approach is employed here. At the inlet boundary, the mass fraction of the diffusing species is set to zero at start when solving for steady state condition to obtain the velocity flow field by solving the equations for laminar flow. The flow field is then frozen and transient simulations were performed by giving a step input at the inlet. A surface monitor point is set to calculate the vertex average mass fractions of the species at the outlet for every time step. The data is presented as a function of flow time in order to obtain the breakthrough curves. 
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 Fig 5.8: CFD model of a tube with resin particles. The particles are randomly placed to imitate the real geometry in Fig 5.8 
5.6.3 Adsorption model Considering species A in the fluid phase (f) is adsorbed on solid sites ( *( )C s ) by a simple mechanism, indicated by the equation 5.3, where *( )C s  represents the number of vacant sites.  
*( ) ( ) ( )a
d
k
k
A f C s AC s∗+ 

                       [5.3] 
*
max( ) A AWC s C C= −                          [5.4] where maxAC is the maximum adsorption capacity when all the sites are occupied and AWC represents the number of occupied sites. AC  and AWC are defined as the concentrations of the adsorbate (MBA) in the fluid phase and at the surface of the particle. A simple adsorption rate model (1st order rate model) was used [212]. The rate of adsorption and desorption is then given by the equations 5.5 and 5.6, respectively. 
Adsorption rate [ ]maxA a A A AWr k C C C= ⋅ ⋅ −                       [5.5] Desorption rate D d AWr k C= ⋅                       [5.6] Where ak  and dk  are the adsorption and desorption rate constants. The thermodynamic constant (distribution coefficient) K  is defined as the ratio of /a dk k . The change in the concentrations in the fluid phase ( AC ) and the solid phase ( AWC ) are given by equations 5.7-5.9. 
[ ] [ ]maxA a A A AW d AW
dC k C C C k C
dt
 = − ⋅ ⋅ − + ⋅                       [5.7] 
[ ] [ ]maxAW a A A AW d AW
dC k C C C k C
dt
 = ⋅ ⋅ − − ⋅                        [5.8] 
a dk K k= ⋅                          [5.9] 
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The parameters, maxAC  and K , are calculated from the adsorption isotherm (section 5.4.2). Parameters 
ak and dk  are estimated based on the kinetic data (table 5.5). Adsorption onto the resin surface is defined in the CFD model by introducing a source term inside the porous domain. This resin has a large surface to volume ratio which was also incorporated into the source term (table 5.5). The source is used to calculate the values of the AC  and AWC , as the adsorption occurs inside the porous domain, by using the mathematical model for the adsorption phenomenon (5.7 – 5.8). The algebraic equations of the mathematical model are solved together with all the other governing equations for fluid flow for every time-step (Appendix 2d).  The particle permeability value is defined as the product of the square of the effective pore diameter and a dimensionless constant which represents the shape and structure of the flow path. The permeability is an intrinsic property of the porous media and thus can be defined as the characteristic property of the resin. However since the permeability values depend on the flow paths the effect of the change in permeabilities to the breakthrough curves needs to be evaluated for each resin (when other potentially influencing factors are kept constant). Thus, simulations were performed by varying the permeability values to obtain higher or lower liquid flow through the particles and check for the sensitivity of the dynamic binding capacity for the permeability values.  Table 5.5: Parameters used for CFD simulations 
Parameters Value Units 
0A
C (Feed) 21.2 kg/m3 
Q (Feed flow rate) 0.26 µL/s 
maxAC  3.2232*10^-6 kg/m2 
Surface area/Volume ratio 7.170007308*10^8 m2/m3 
ak  0.52 m3/kg s 
dk  1 1/s Pore and surface diffusivities depend on the pore size and its distribution and the diffusing species. Thus they are a function of the resin particle and the specific adsorbate. Simulations were also performed by varying the surface and the pore diffusivities inside the particles to check for the sensitivity of the dynamic binding capacity for these parameters. By fitting the model to the available data, it was also attempted to estimate the permeability and the diffusivities.  
Microscale packed bed columns and CFD as screening and design tools for solid phase extraction  
66  
5.7 CFD simulations For the isotropic loss model in CFX [211], the permeability coefficient ( permK ) and the resistance loss coefficient ( lossK ) have been estimated to be 2.47*10-12 m2 and 6.72*106 m-1 respectively (Appendix 2e). An initial simulation was performed by assuming the values of pore and surface diffusivities to be an order of magnitude smaller than the aqueous diffusivity in the fluid phase. Contour plot and velocity vectors of velocity profiles are plotted in Fig 5.9 a and b. The contour plot (Fig 5.9a) shows the internal zones (flow phases) where the velocities are highest in the middle. This shows that as the fluid flow interacts with the porous particles, the velocity decreases and the flow deflects (Fig 5.9b) around the porous particle. The mass transfer direction is from the fluid phase to the stationary particle by intraparticle diffusion. Deflection of the flow can be observed by making a streamline analysis of the flow, Fig 5.10 a and b. The velocity vectors are coloured according to the magnitude of the velocities magnitude (legend: blue to red – minimum to maximum).  
a)    
b)     Fig 5.9: a) Contour plot of velocity; and, b) vectors of velocity on a longitudinal plane in the middle of the tube Densely packed beds (smaller particle sizes) with less void volumes have fewer flow phases and more stationary phases due to the increased interaction with the particles (higher number of particles). For loosely packed beds, formation of a plateau has been observed in the breakthrough curves where the concentration at the outlet remains almost constant for a time period and then a spike was observed to reach the final concentration (Appendix 2f). This can be understood as there was less formation of 
Internal Zones  
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stationary phases (continuous flow phase with no particle interactions) and the flow is split between convection through the particle and convection through the rest of the bed. The development of stationary phases with decreasing particle sizes has also been observed by Boysen and co-workers for HPLC column [213]. The authors have emphasized that decreasing particle sizes leads to development of stationary phases, decrease in permeability of the bed and increase in pressure drops over the column.  Feed flow rates influence the residence times of the internal zones inside the column. At higher feed flow rates, the internal zones would have shorter residence times in the column and thus relatively higher concentrations would be produced at the outlet. This also means that at higher flow rates, the feed would leave the column before the equilibrium adsorption is reached, thus decreasing the product removal efficiency. The higher loading ( adsn ) achieved at lower flow rates in a µ-PBR system (Table 5.5) indicates higher residence times for the internal zones and thus higher mass transfer from the fluid phase to the particle by intraparticle diffusion. Thus, the breakthrough curve depends on the packing intensity and flow rate (assuming same kinetics and diffusivities).  
a)     b)   Fig 5.10: Streamlines of flow: a) between two particles, forming an internal zone; b) showing the deflection of flow around the particles and the particle trajectory (coloured by velocity magnitudes) Transient simulations were performed by giving a step input to the species concentration at the inlet. The contour plots of the species concentration in the fluid and the porous domains (Fig 5.11) show that the hydrodynamics of the flow around the particle has an influence on the intraparticle diffusion. The simulations also show the intraparticle diffusion mechanism and the gradual filling of the particles from the outer shell to the inner shell. Particles closer to the inlet get saturated before the following consecutive particles. The simulations also show the lack of plug flow behaviour and the occurrence of longer adsorption zones inside the bed. This can be attributed to loose packing, slower kinetics or the limitations to intraparticle diffusion. Augier and co-workers have also developed a similar model to 
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simulate the adsorption of chemical species inside different geometries and have also found that hydrodynamics has a strong impact on the adsorption efficiency [214].  
a) b)  
c) d)  Fig 5.11: Adsorption through the bed at different time intervals following a concentration step input at the inlet at t=0: a) After 3.67 s; b) After 19.21 s; c) After 112.27 s; d) After 158.35 s 
 
5.7.1 Parameter estimation and sensitivity analysis Such an integrated CFD model can be used to estimate the permeability and intraparticle diffusivities by retrofitting with experimental data. It is realistically assumed that the surface diffusivity is 10 times slower compared to that of the pore diffusivity [215]. The best fit (Fig 5.12) was observed with permeability of 10-13 m2 and pore and surface diffusivities of 10-9 and 10-10 m2/s respectively. The amount adsorbed ( adsn ) was calculated based on the equation 5.2 to be 1.82 mmol/g which was considerably less as compared to the investigated µ-PBR (Table 5.5). This can be attributed to the loose packing of the resins in the tube as compared to the µ-PBR and thus less liquid flow through the particles as observed in earlier simulations. This phenomenon can also be observed through the formation of the plateau in the breakthrough curves (see Appendix 2f).  The determination of which resin is best suited for the process depends on the breakthrough point (to estimate the volume of the stream that can be treated before the product leaves the column) and the steepness (plug flow behaviour) of the breakthrough curves. The breakthrough curve, measured continuously as the adsorbate concentration at the outlet, is a function of the hydrodynamics, diffusivities, particle permeability and adsorption kinetics. Thus varying any one of the parameters has an influence on the shape of the breakthrough curves. It is intended to make a sensitivity analysis of some of these parameters. The integrated CFD model can be used for predicting the impact of changes in the process, and further assist in the design of a packed bed column. 
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 Fig 5.12: Estimating parameters by fitting a mathematical model to the experimental data Simulations were performed by fixing the pore and surface diffusivities and varying the particle permeabilities to obtain higher liquid flows through the particles. The results  (Fig 5.13 a, b) show that the particle permeability has a significant influence on the dynamic binding capacity. The break-through (breakpoint) for various conditions happens almost at the same time meaning that it only depends on the hydrodynamics, packing intensity and flow rates. However, the trajectory of the curve depends on the liquid flow through the particles. Based on the simulations, as the permeability increases from 10-14 to 10-12 m2 (Fig 5.13a), lower product concentrations were achieved at the outlet. This signifies that the increase in permeability leads to increased performance in the product removal and thus giving lower concentrations at the outlet. This trend can be explained by the effect of fluid flow through the packed bed. Lower particle permeability leads to an increase in flow velocity and consequently reducing the residence time in the bed and higher product concentrations at the outlet. Owing to the large surface to volume ratio for this resin, it can be anticipated that a higher amount of the product was adsorbed ( adsn ) for higher liquid flow through the particles which indicates that the bottleneck here is the particle permeability. Similar results can be observed in Fig 5.13b with lower pore and surface diffusivities.  
Pore diffusivity – 10-9 m2/s Permeability – 10-13 m2 Experimental data 
Microscale packed bed columns and CFD as screening and design tools for solid phase extraction  
70  
a)  
b)  Fig 5.13: Parameter sensitivity analysis - Breakthrough curves for varying permeabilities: a) pore and surface diffusivities of 10-9 and 10-10 m2/s, respectively; b) pore and surface diffusivities of 10-10 and    10-11 m2/s, respectively Further, simulations were performed with the same particle permeability while varying the pore and surface diffusivities. From Fig 5.14, it can be observed that the effect of the pore and surface diffusivities is less significant as compared to particle permeability for this resin.  
5.8 Discussion  The understanding of detailed fluid flow is crucial for packed-bed column design since the mass transfer in a packed bed is influenced by the column hydrodynamics. From the simulations, it can be anticipated for this resin that the bottleneck is attaining higher liquid flows through the particles. The porosity of this resin is calculated to be 0.09 which is much less in comparison to ion-exchange resins 
10-14 m2   10-13 m2 10-12 m2  
3-12 m2  5-12 m2  10-12 m2  
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and so is the particle permeability which is directly proportional to the cube of the porosity according to Kozeny’s equation. Maintaining the same tube-to-particle diameter ratio, similar fluid flow profile can be anticipated for large scale packed bed columns using this resin. Thus in order to achieve higher loadings and more plug flow behaviour, strategies such as high density packing, lower flow rates and/or smaller particle sizes need to be employed. 
  Fig 5.14: Parameter sensitivity analysis - Breakthrough curves at the outlet of the tube for varying pore diffusivities and permeability of 10-12 m2 through the particles Using the integrated CFD model with estimated pore and surface diffusivities, further simulations can be performed with varying tube-to-particle diameter ratios and flow rates to check for the effect of this on the breakthrough curves. Further, the effect of inlet feed concentrations on the adsorption process and the breakthrough curves also need to evaluated. For efficient design of fixed beds, a more systemic approach is needed in which important features of the flow could be identified and linked to the structural features of the bed, such as particle size, shape and the tube-to-particle diameter ratio. As described by Dixon and co-workers, a structure based approach to mass transfer is an attractive option to perform fixed bed modelling instead of using theoretical models (effective parameters) [216]. CFD simulations could help a great deal in identifying such information and could thus make a strong impact on design. Further work should focus on validation of the simulations (at varying feed flow rates and inlet feed concentrations) using experimental data. Design of the large scale packed-bed column should be based on the results from such simulations. These simulations are however not performed here because of time limitations. Furthermore, the integrated CFD model can be used to investigate the behaviour of other sorption isotherms (ion exchange resins etc). 
10-9 m2/s 10-10 m2/s  10-11 m2/s  
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5.9 Conclusion Synthetic resins are attractive options to be used as auxiliary phase for ISPR for biocatalytic reactions. External packed bed systems with indirect contact to the resins form an attractive configuration for separating the product from the enzyme and maintaining product concentrations below inhibitory levels inside the reactor. However, selecting synthetic resins for ISPR in an external packed bed column configuration requires a screening and design methodology, and in the work done here it is attempted to develop a systematic procedure for screening and characterizing the resins using a µ-PBR and CFD as screening and design tools. Resins can be characterized based on higher capacities and faster kinetics, higher affinity towards adsorbate (product) and packed column design (particle size, packing intensity, flow rates) should be based on attaining higher loadings and plug flow behaviour (steep breakthrough curves) under a wide range of process conditions.   A case study here demonstrated the methodology to screen resins for the product MBA (Fig 3.1) from a group of hydrophobic and ion-exchange resins. Initial experiments at batch scale were performed for screening resins with higher capacities. Later, the affinity of the resins towards the adsorbate is checked for by making sorption isotherms of the distribution of adsorbate between the resin and the aqueous phases. Using a µ-PBR system, the resins are screened for breakpoints (volume of the liquid that can be treated before the efficiency decreases) and dynamic loading at different operational conditions (flow rates). Higher loadings ( adsn ) were achieved using the µ-PBR when compared to batch systems which indicates a better mass transfer in a packed column configuration.  For design of fixed beds, theoretical models for the intraparticle mass transfer and adsorption have been used by researchers to predict the breakthrough curves [217, 218] but these models cannot be applied widely to include the effect of hydrodynamics. An integrated CFD model including the hydrodynamics, intraparticle diffusion mechanism and adsorption kinetics is developed here to predict the breakthrough curves for different conditions. Values for bed permeability and diffusivities were approximated by fitting the model to experimental data. On the basis of a parameter sensitivity analysis, the model predicts that a plug flow behaviour of the breakthrough curves can be achieved for the resin by increasing the particle permeability. The changes to pore and surface diffusivities on the other hand had least effect on the breakthrough curves for this resin indicating that the bottleneck is the permeability of the resin. Teruel and co-workers have used a similar approach of characterizing the porous media based on permeabilities and pressure drop evaluations using numerical tools [219]. Reactor designs can be customized based on the increased understanding gained from the CFD simulations before making a full scale industrial process.   
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6 Integrated micro-membrane packed-bed reactor: 
screening tool for process development of 
biocatalytic reactions 
This chapter deals with the development of customized integrated microsystem that can be used as an effective screening tool, which is demonstrated by means of selected case studies.   
6.1 Introduction:  Biocatalytic processes, as compared to traditional chemical catalytic processes, offer some extra degrees of freedom when performing process screening, such as the enzyme form, CFE or WC, the potential to use several enzyme variants, stability of the enzyme, enzyme inhibition by substrate or product, economic viability and feasibility of scale-up [220]. Stability of the enzyme and inhibition of the enzyme activity by substrate or product are important in determining the appropriate reactor type, and the most suitable operation conditions and biocatalyst form. Thus, when a stable enzyme with high enantioselectivity is acquired through protein engineering, the next critical problem in the successful industrial process development would be to get rid of or reduce enzyme inhibitions and improve enzyme stability. Further sensitivity to co-factors, buffers, temperature and pH adds up to increase the complexity enormously. Moreover, in many cases low substrate solubility also becomes an issue [154].  As discussed in chapter 4, the modularity of screening for process alternatives at microscale enables fast screening of various process techniques for identifying economically feasible alternatives, and relies on comparing predefined process metrics among the tested process alternatives. An integrated modular microsystem has a number of features that are advantageous for rapid screening with respect to improved economy of the proposed process and process development: 1) potential for high throughput experimentation; 2) the system process intensity is inherently enhanced through continuous operation; 3) large sets of data can be obtained while consuming significantly lower amounts of expensive reagents; 4) Modularity allows for customized experimental set-ups. Two case studies are presented where customized integrated microsystems are built and used to screen the enzyme form, process conditions, optimize the process performance, and to characterize process solutions for industrial viability. 
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6.2 Case studies  
6.2.1 Synthesis of imines catalysed by Monoamine oxidase (MAO)  Oxidation reactions using enzymes are increasingly in focus in the pharmaceutical industry because of the possibility to use mild oxidants (oxygen). Biocatalysis using amine oxidases has been shown to be an attractive option for the production of imines, compounds which are of particular interest to the pharmaceutical industry [221]. As such here monoamine oxidase (MAO) catalysed oxidation of a secondary amine (Fig 6.1) is selected as a case study to demonstrate the application and integration of various process techniques at microscale for overcoming process challenges. The imine product is an intermediate in the production of the commercial drug telaprevir (Merck) [222, 223].  
 Fig 6.1: Oxidation of amine to imine catalysed by monoamine oxidase 
6.2.2 Synthesis of optically pure chiral amines using ω-Transaminase (TA) As discussed in chapter 3, biocatalytic transamination for the production of chiral amines is commercially attractive for synthesis of pharmaceuticals and precursors. As such the synthesis of (s)-1-methyl-3-phenylpropylamine (MPPA) with acetone (ACE) as co-product, and using benzylacetone (BA) and isopropylamine (IPA) as starting materials (Fig 6.2) is selected here as a case study to demonstrate the application and integration of various process techniques at microscale. The reaction 
is catalysed by ω-transaminase, in the presence of a co-factor Pyridoxal-5’-phosphate (PLP), by transferring the amine group from the amine donor to a pro-chiral acceptor ketone, yielding a chiral amine along with a co-product ketone.  
 Fig 6.2: Biocatalytic transamination by ω-Transaminase 
(s) -ω-transaminase PLP C H 3 
N H 2 + C H 3 
O + N H 2 C H 3 C H 3 Isopropylamine  (IPA) 
O 
C H 3 C H 3 Acetone (ACE) -1-methyl-3-phenylpropylamine (MPPA) 4-phenyl-2-butanone (BA) (S) 
N 
MAO 
N H O 2 H O 2 
Integrated micro-membrane packed-bed reactor: screening tool for process development of biocatalytic reactions 
75  
For process development, it is crucial to identify limitations and targets for the reaction. A systematic approach has been used first by identifying the process limitations at batch scale and then applying process techniques and comparing the performance with the batch set-up.  
6.3 Materials and methods 
6.3.1 Medium and Chemicals Technical grade reagents were procured and used without further purification. All chemicals are procured from Sigma-Aldrich unless specified. Aza-bicyclo-octane HCl was procured from AK Scientific, (Union city, CA, USA) and Hydrochloric acid (HCL) was procured from Merck. Pebax 3533 polymeric resin, a thermoplastic elastomer made of flexible polyether and rigid polyamide, was obtained from University of Queens and used for the extraction of the imine. Lewatit AF5 resin, a microporous carbonaceous material, was procured from Sigma-Aldrich and used for the extraction of amine (MPPA). 0.2 µm hydrophobic PTFE membranes (100 mm diameter) were procured from Millipore Inc A/S and 10 kDa MWCO hydrophobic PES membranes (150 mm diameter) were procured from Sartorius AG A/S. The membranes were cut with a scissor to the required diameter and soaked in water for 1 hr before use.  
6.3.2 Production of biocatalysts  
E.coli BL21 cells, expressing the MAO, were obtained from European Union's Seventh Framework Programme BIONEXGEN. LB broth was made with 10 g/L tryptone (Nordic biolabs AB, Täby, Sweden), 5g/L yeast extract (Nordic biolabs AB, Täby, Sweden) and 10 g/L sodium hydroxide. To this, 2% (w/v) agar was added for making plates. The agar was added just prior to plating. The broth was autoclaved and ampicillin (filter-sterilized) was added to the broth (100 µg ampicillin/mL media) prior to use. The E. coli BL21 cells were streaked onto an LB plate containing 100 µg/mL ampicillin. The plate was incubated at 37˚C overnight. 3 mL of LB broth containing 100 µg/mL of ampicillin was inoculated with a colony from the LB-Amp plates. The pre-culture tube was incubated at 30˚C in a shaker at 150 rpm for about 4 hours. To unbaffled shake flasks containing 100mL of LB broth, 1mL of pre-culture was added (1% inoculum). The flask was incubated on a shaker at 30˚C and 150 rpm. Cells were harvested after 18 h of growth by centrifugation at 4000 rpm for 20 min. The harvested cells were re-suspended in 100 mM potassium phosphate buffer at pH 7.6 and used for biocatalysis. 
E.coli BL21 cells, expressing the TA (ATA-47), and the corresponding unpurified CFE, as lyophilized powder, were obtained from c-LEcta Gmbh (Leipzig, Germany). The culture medium (ZYM505) was composed of ZY, M, 505 and 2 mM MgSO4. ZY was prepared using 5 g/L of Yeast extract and 10 g/L of tryptone; M was prepared using 0.5 M of Na2HPO4, 0.5 M KH2PO4, 1 M NH4Cl and 0.1 M Na2SO4; and 
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505 was prepared using 250 g/L of glycerol and 25 g/L of glucose. The broth was autoclaved and 
supplemented with 50 μg/ml kanamycin prior to use. 2% (w/v) agar was added for making plates. 
One colony from the plates was cultivated in complex media ZYM505 and 50 μg/ml of kanamycin in a 3ml pre-culture tube and incubated overnight at 37 °C (150 rpm). To unbaffled shake flasks containing 100 mL of ZYM505 broth (50 μg/ml of kanamycin), 1 mL of pre-culture was added (1% inoculum). The flask was incubated on a shaker at 30˚C  and 150 rpm. The cultures were induced with 1 mM IPTG in the early exponential phase (OD600 = 0.6-0.9) and harvested by centrifugation (4000 rpm, 20 min,    20 h after inoculation). The harvested cells were re-suspended in 100 mM potassium phosphate buffer at pH 7.4 and used for biocatalysis. 
6.3.3 Analytical method A reverse phase HPLC method (Ultimate 3000 HPLC equipped with UV detector and photodiode array detector) was used for analysis of MPPA and BA. A Luna® 3 µm C18 (2) 100 A (50x4.6mm) column (Phenomenex) was used to detect the compounds at a flow rate of 2 mL/min using a multistep gradient flow of aqueous 0.1%(v/v) trifluoroacetic acid and acetonitrile (99.8%) with the following volume percentage of acetonitrile: 0 min (5%), 1 min (10%), 2.5 min (10%), 5.9 min (60%), 7 min (5%). The compounds were quantified at wavelengths of 210nm for MPPA and BA, with retention times of 4.0 and 5.9 minutes respectively.   Aza-bicyclo-octane HCl was analysed in a J&W CAM gas chromatography column (Agilent Technologies, Hørsholm, Denmark) by Clauris 600 GC-FID (Perkin Elmer, Skovlunde, Denmark) with a split injection ratio 50:1. An isothermal method with the column, injector and detector temperatures at 110˚C, 250 ˚C and 250 ˚C respectively was used. The carrier gas (nitrogen) flow-rate was set to 1.6 mL/min. The detector gases included air and hydrogen flowing at a rate of 350 mL/min and 45mL/min respectively. Samples were prepared for the analysis by adding 200 µl of reaction mixture to an eppendorf tube containing 10 µL of 10M sodium hydroxide and 100µL of 1% (v/v) 1-phenyl ethylamine (MBA) (Merck, Germany). To this, 1mL of methyl tert butyl ether (MTBE) was added, vortexed for ~20 seconds and centrifuged (Eppendorf, Horsholm, Denmark) at 14100 rpm for 5 min. The supernatant was then transferred to another eppendorf tube and dried with sodium sulphate. This was then vortexed and centrifuged. 200 µL of the organic phase was then transferred to GC vials for analysis. 
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6.4 Batch experiments  For the case using TA as WC, a biotransformation experiment was conducted in a 4 ml vial (working volume of 3 ml) in a thermal shaker (no heating). 1.48 g/L of initial substrate concentration was used and 10 g/L of WC concentration was used.   
6.4.1 Results For the case-study using MAO, batch experiments for substrate and product inhibition studies were performed by Ramesh [224]. From the inhibition curves targets for operating conditions can be obtained. From the inhibition curves [224], it can be deduced that the enzyme activity  decreases significantly at substrate concentrations above 14 g/L and product concentrations above 0.15 g/L. Higher product concentrations have considerable inhibitory effects on enzyme activity which indicates the need for effective and fast removal of the product. So it is intended to use ISPR using resins in an external packed column format, and to employ a fed-batch substrate supply for retaining high enzyme activity and thus increasing the productivities.  For the case study using TA as CFE, batch experiments for studying inhibition of enzyme activity studies were performed by Lima [181]. From the inhibition curves, it was observed that enzyme activity (CFE) decreases significantly at product concentrations above 0.1 g/L. At product concentrations above 1 g/L, the enzyme activity decreases by more than 80%. Thus product concentrations have considerable inhibitory effects on enzyme activity which indicates the need for effective and fast removal of the product requiring ISPR.  Lima has also observed the highest rates, for this enzyme in whole cell form, at a substrate concentration of 1.482 g/L [181]. As such biotransformation using WC batch experiments (Fig 6.3) were done with the specified substrate concentrations and the maximum conversion that could be attained was 84% after 23 hrs. The initial rate was measured to be 0.7552 g/L hr which was similar to that observed by Lima.  
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 Fig 6.3 Biotransformation for the synthesis of MPPA 
6.5 Integrated micro-membrane packed bed reactor (IMMPBR) Enzyme membrane reactors (EMR) have been used in biotechnology and particularly for biocatalysis because of the possibility to retain and reuse the macromolecular enzyme (compared to substrates and products) by use of a membrane. Different configurations of EMRs were built which included enzyme segregation by a membrane module or entrapment of the enzyme inside membranes or immobilization onto membrane surfaces [225-227]. These different configurations can be run in continuous stirred tank reactor (CSTR) mode or plug flow mode and are used in the agro-food industry for instance for hydrolysis of pectins in fruit juices etc [228-230]. However optimization of an EMR involves a lot of experimentation work because there are a considerable number of optimization parameters. Miniaturizing the EMRs will be beneficial for biocatalyst and process screening, and for optimizing the performance at the early stage: continuous experiments indeed save a lot of experimentation time and resources, and thus form an asset in the biocatalytic process development toolbox [231]. Muller and co-workers have designed the micro enzyme membrane reactor (MEMR) and operated as a loop reactor with a volume of less than 200 µL. They have showed that using an MEMR the amount of substrates used for continuous reactions was lowered by 50 times for enantioselective reduction of ketones by alcohol dehydrogenase [231]. Hisham has demonstrated the operation of a continuous membrane microbioreactor, operated as a loop reactor, for pectin modification and separation processes along with optimization of parameters such as enzyme to substrate ratio, substrate feeding rate and membrane molecular weight cut offs [232]. The authors have shown that a loop reactor (operated with high recycle to feed flow ratio) can achieve suitable residence times and shows identical behaviour to CSTRs. Pohar and co-workers have demonstrated 
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the integration of the reactor module (packed-bed) with the membrane module for continuous product separation at micro-scale [137]. Such modules at microscale can thus be used as scaled-down experimental set-ups for process design and optimization studies. Mathematical models can be further used to predict and optimize the process performance. As such, in order to effectively control the concentrations of the substrate and product inside the reactor, it is intended here to construct an EMR, operated as a reactor with recycle loop, where the reagents are continuously supplied into the reactor while the product is continuously removed. At steady state, the conversion is controlled by the enzyme concentration and the residence time. Fig 6.4 visualizes, using an integrated micro enzyme membrane reactor system, how different process strategies can be integrated into one system while both intensifying the process and screening and optimizing the process performance. Since the prototypes are easier to manufacture multiple experiments can be performed in parallel with different experimental conditions.  
IMMPBR
Easier product 
extraction for 
downstream 
processing
Integrated product extraction using SPE
Modular design for different experiments No mass transfer limitations as compared to immobilized systems
Free enzyme and whole cell biotransformations
Possibility of maitaining uniform operating conditions for enzyme
Stability testing of enzyme at operational conditions
Process Intensification
Controlled substrate supplyOperational mode; continuous, Batch and Fed-batch
 Fig 6.4: Concept visualization of IMMPBR A modular reactor set-up (Fig 6.5) with integrated processes at micro-scale, IMMPBR, was designed and tested to address process issues and limitations. The modular set-up is designed to consist of a reactor module, a packed-bed extraction unit using synthetic resins for ISPR, fed-batch operation for 
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continuous substrate supply and a recycling loop through the reservoir. This set-up is comparable to a MEMR system where the product is continuously extracted as an outflow while in the IMMPBR the product is continuously extracted using resins. The mixing inside the reactor module is achieved by magnetic stirring which is active mixing and comparable to that of large scale industrial systems [233]. The reactor can be operated with WC or CFE. WC processes are the most economical with respect to the absolute cost of the catalyst [8]. However there could be challenges such as mass transfer across the cell membrane and undesired side reactions. A physical membrane is used to retain the biocatalyst inside the reactor. Retaining the enzyme using a membrane ensures maintaining its full activity as compared to immobilization techniques where the enzyme loses its activity due to entrapment or immobilization. Membrane properties also play an important role in determining the separation efficiency and flow through the membrane. The membrane molecular weight cut-off should be selective enough for retaining the enzymes while allowing other components of the reaction mixture. The membrane should further also have very low protein adsorption.  The integrated system can be operated in batch, continuous and fed-batch mode. As discussed, continuous mode is achieved by operating the system as a reactor with recycle loop. Fed-batch operation can be achieved by eliminating the recycle loop. In continuous mode, the residence time inside the reactor is controlled by the fed-batch substrate feed rate and the recycling rate while the inlet substrate concentration is controlled by the amount of unreacted substrate in the outflow stream from the reactor and from the effluent stream of the packed bed column. The resin loading inside the packed column is another operating variable that needs to be optimized based on the effluent concentrations from the packed column that can be obtained from the breakthrough curves for the substrate and the product. The maximum operational time for the IMMPBR will thus be dictated by the breakpoint and the breakthrough curves for the packed bed column with the specific resin to determine the maximum volume that can be treated before the substrate and the product concentrations in the effluent stream reach the critical values for inhibition. Thus, the substrate feed rate, recycling rate and the resin loading all need to be optimized accordingly to match with the reaction kinetics in order to obtain below inhibition level substrate and product concentrations inside the reactor. Process optimization can be carried out efficiently to determine the enzyme operating conditions that can be optimized to mimic the industrial scale. Since the reactor configuration is identical to industrial scale, the optimization scenario can be potentially used for direct scale-up. Furthermore a substrate feeding strategy can be employed, based on the effluent concentration in the recycle loop, to obtain uniform inlet substrate concentrations at the inlet of the reactor. The feeding strategy can be developed based on a mathematical model which can, however, be quite complicated: the model should include a kinetic model for the reaction, a diffusion model 
Integrated micro-membrane packed-bed reactor: screening tool for process development of biocatalytic reactions 
81  
through the membrane and a packed bed column model to predict the breakthrough curves. Also, other optimization parameters such as mixing studies, effect of mixing time, stirring speed etc on the enzyme activity, can be performed at this scale. The enzyme to substrate ratio (E/S) which is an important parameter in biocatalytic reactions, to obtain the desired kinetic performance, can also be optimized at this scale. However for the work done in this project, the substrate feeding strategy and other optimization parameters are not considered for evaluation of the process performance.  
Reactor module
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Product
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Resin loading(g/L) Flow rate (Bed volume/hr)
Enzyme concentration(g/L)
Packed bed with resins
Platform with a possibility of heating
  Fig 6.5: Integrated micro membrane packed bed reactor (IMMPBR) set-up 
6.5.1 Modules and experiments  The microreactor module was built using polymethylmethacrylate (PMMA) (Nordisk Plast) by a CNC assisted micro-milling technology. The micro-milling machine, Mini-Mill/3, was procured from Minitech Corporation (USA) and the spindle and controller, E3000C, were procured from NSK America Corp (Nakanishi Inc.). The reactor module has a working volume of ~700 µL. Please refer to Appendix 3a for schematic diagrams. SolidWorks software (Dassault Systèmes SolidWorks Corp) was used for creating the geometry and generating the G-code for the milling machine. Polytetrafluoroethylene (PTFE) tubes were used as packed bed column modules. The tubes were filled with the resins and 
Integrated micro-membrane packed-bed reactor: screening tool for process development of biocatalytic reactions 
82  
sealed using a smaller tube whose external diameter corresponds to the internal diameter of the packed column tubing. The seal is leak proofed using Teflon tape. The modules were pre-tested for leaks at different flow rates before integrating them with the reactor module.  A modular digital pump, Cavro XL 3000 from Cavro scientific instruments Inc. (controlled using the software LabView) was used for recycling the stream through a reservoir  module (4 ml glass vial with stirring). A Harvard single syringe pump (model no. 70-2208) was used for the substrate supply in fed-batch mode. For the recycling flow a three-way flow fluidic connector (PEEK) from Mikrolab Aarhus A/S has been used. Standard connectors, screws and ferrules (PEEK), were procured from Mikrolab Aarhus A/S for connecting the fluidics. The experiments were performed under continuous flow conditions. The experimental design, in terms of loading and pumping steps, was coded in LabView. The membrane microreactor module, packed bed reactor module and the PTFE tubings were put together (Fig 6.5 and Appendix 3a).  6.5.1.1 MAO system The system is operated with a total volume of 3 ml of reaction mixture containing 100 mM phosphate buffer at pH 7.6. Biocatalyst (harvested cells), suspended in ~700 µL of buffer at a concentration of    5.6 g CDW/L, is added to the reactor module under magnetic stirring and no heating (no temperature control). A 0.2 µm PTFE membrane (17 mm diameter) and a gasket are placed on top of the reactor and the lid is sealed to close the reactor module. The remaining buffer (~2.3 mL) is added to the reservoir, which is a 4 ml glass vial with magnetic stirring. The outlet of the reactor module is connected to the packed column module. The packed bed column module is prepared by weighing ~298 mg of the Pebax 3533 polymeric resins and subsequently loading them in a PTFE tube of diameter 3 mm. The concentration of the resin is ~100g/L of reaction mixture. The outlet from the packed bed column module is pumped back into the reservoir. Thus the reaction mixture is continuously recycled through the system at a rate of 10 µL/min for ~30 min before adding the substrate. Substrate, Aza-bicyclo-octane HCl, is prepared at a concentration of 45 g/L and added to the recycle flow at a rate of 1.1 µL/min. Thus the system is operated with a total inlet flow rate of 11.1 µL/min for 15 hrs before the final samples were collected from the reactor and the reservoir for later analysis. This gives a residence time of 63 min. The product is extracted from the resins using methyl tert-butyl ether (MTBE) at a flow rate of 10 µL/min for 10 hrs.  6.5.1.2 TA system The system is operated with a total volume of 1.2 ml of reaction mixture containing 8 mM PLP, 100 
mM phosphate buffer and 1M IPA at pH7.4. Biocatalyst, ω-transaminase (ATA-47) , was suspended in ~700 µL of reaction mixture at a conc. of 5 g/L for CFE and 10 g/l for WC in the reactor module with 
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magnetic stirring and no heating (no temperature control). A 0.2 µm PTFE membrane (17 mm diameter) and a gasket were placed on the top of the reactor and the lid was tightly screwed to close the reactor module. The remaining reaction mixture (~500 µL) was added to the reservoir, which is a 4 ml glass vial with magnetic stirring. The outlet of the reactor module is connected to the packed column module. The packed bed column module is prepared by loading Lewatit AF5 resin in a PTFE tube of 1 mm diameter at a concentration of 80 – 200 g/L of the total system volume. The outlet from the packed bed column module is pumped back into the reservoir. Thus the reaction mixture is continuously recycled through the system at a rate of 1 – 4.8 µL/min for ~30 min before adding the substrate. Pure substrate, BA, at a concentration of 987 g/L is added to the recycling flow at a rate of 1.5 - 5.9 µL/hr. The system is operated for 37 hrs before the final samples were collected from the reactor and the reservoir for analysis. Experiments were performed as shown in table 6.1. Product is extracted from the resins using pure acetonitrile at a flow rate of 1 bed volume (BV)/hr for 10 hrs. Table 6.1: Experimental conditions tested         
Experiment 
Resin loading 
(g/L) 
Recycling rate 
(µL/min) 
Substrate flow 
rate (µL/hr) 
WC1 80 4.8 5.9 
WC2 200 2.8 1.5 
CFE1 80 4.8 5.9 
CFE2 100 4.8 5.9 
CFE3 133 4.8 3 
CFE4 150 4.8 1.5 
CFE5 150 1.0 1.5 
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6.6 Results and discussion The IMMPBR is intended to be operated at low working volumes and with no outflow (with the recycling loop operational mode while the product is continuously extracted using resins). Since the minimum sample volume needed is about 200 µL for the analytical method used, it is impractical to obtain intermittent samples.  An online analysis method would thus be quite beneficial in order to estimate the product formation rate and kinetics etc. However here it is intended to test the performance of the system for process viability and scale-up to industrial scale based on the process metrics described in chapter 4. Thus, only end samples are obtained and analysed to evaluate the amount of product formed as compared to the batch system. 
6.6.1 MAO system The performance of the IMMPBR system is evaluated compared to the batch system while keeping the same enzyme loading (g of enzyme/L of total system volume). However since the substrate is loaded as a fed-batch in IMMPBR, the E/S ratio varies depending on the substrate inlet flow rate. In the batch system, biocatalysis was performed in baffled shake flasks on a thermal shaker at 37 0C and 150 rpm [224] while in the IMMPBR system there is no temperature control and the mixing is achieved by a magnetic stirrer rather than shaking. All these factors have effect on the mass transfer, kinetics and the final performance. However, the industrial viability of these operational modes and parameters can be compared based on the process metrics [45] both for the batch and IMMPBR operation. In the batch system, Ramesh and co-workers [224] have shown that the reaction reaches the final conversions after about 24 hrs of operation for different initial concentrations of the substrate. Since complete conversions were achieved at lower substrate concentrations for this reaction [224], the authors have concluded that thermodynamic equilibrium is not expected to be the limiting factor. For different initial substrate concentrations it takes about 15 hrs of operation before it reaches ~90 % of its final value (after 24 hrs) [224]. As such 15 hrs of operational time is selected for the microreactor system to compare with the batch system. For the microreactor system, the substrate is loaded at a concentration of 45 g/L and flow rate of 1.1 µL/min for 15 hours which gives a total substrate loading of 44.6 mg. In the batch system, with a working volume of 20 ml in a baffled shake flask, a similar substrate loading corresponds to a concentration of 2.3 g/L. Ramesh and co-workers have shown the conversion plot for the initial substrate concentration (~2.5 g/L) for this reaction and this data has been used here for comparing the performance at batch scale and IMMPBR [224]. The amount of product produced is based on the amount of substrate converted both for the batch system and the IMMPBR (because of the inability to extract the complete product from the resins).  
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a)                b)            c)    
d) e)  f)  Fig 6.6: Aqueous concentration in the reactor module of: a) Substrate b) Product, where the inhibition level concentrations to the enzyme activity are marked with dashed lines; Comparing the IMMPBR performance with the batch for the process metrics: c) Biocatalyst yield; d) Substrate yield;                   e) product concentration; and f) STY    
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 For IMMPBR the aqueous concentration in the reactor at the end point measurement is analysed which shows that the concentrations for the substrate and the product inside the reactor were below the inhibition levels (Fig 6.6 a, b). This shows the workability of the integrated system to be able to achieve the target values for below inhibitory level concentrations inside the reactor. Intermittent samples for the product formation and the substrate consumption would further help in understanding the reaction performance. Different reactor set-ups with varying residence times or without recycling loops can be further set up to study and evaluate the performance.   Compared to the batch system, biocatalyst yield (Fig 6.6 c) increased by more than 12 times. This is however based on the assumption that for the batch set-up biocatalyst cannot be recovered or recycled. Also, about 29 times lower amount of enzyme is used for the microsystem as compared to batch system. However, from the substrate yield (Fig 6.6 d), it can be observed that only 49% of the substrate was converted compared to 92% at batch scale. So if we consider the ratio of enzyme used to substrate converted, the microsystem has a 13.2 times lower ratio of enzyme used to substrate converted meaning that 13.2 times higher amount of substrate can be converted with the same amount of enzyme using the microsystem as compared to the batch system. The decrease in substrate yield in the microsystem compared to the batch system indicates that the selected resin is not selective enough towards the product and some amount of the substrate is sorbed to the resin. Thus, the challenge now reduces to screening of various resins under operational conditions for selective removal of the product and not the substrate. Higher product concentrations (Fig 6.6 e) were observed for the microsystem (5.3 g/L) as compared to the batch system (1.73 g/L) and similarly higher volumetric productivities (Fig 6.6 f) were attained in the microsystem (0.355 g product/L.h) compared to batch system (0.115 g product/L.h).   The secondary substrate for this reaction is oxygen which was supplied by a large head space (250 ml baffled shake flask with 20 ml working volume) and continuous shaking (150 rpm) at batch scale [224]. It has been shown that at batch scale the reaction is not limited by oxygen for these enzyme and substrate concentrations. Oxygen transfer in the microsystem was achieved by continuous stirring in the reservoir by which the inlet stream entering the reactor is saturated with oxygen while supplying the substrate (fed-batch). Thus experiments were performed with no direct oxygen supply to the reactor. The better performance of the microsystem compared to the batch system might indicate that oxygen is not the limiting factor also at microscale with the given enzyme and substrate concentrations. However, the implication can also be that, with the ability to obtain below inhibitory 
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level concentrations for substrate and product inside the reactor, the bottleneck has now shifted to oxygen limited reaction. More experiments with and without direct oxygen supply need to be performed at this scale in order to gain more process knowledge. It can be concluded that for the synthesis of imine catalyzed by MAO, the IMMPBR system has a better performance compared to the batch system for all the process metrics considered. However the resin considered for product extraction is not selective enough towards the product. Further experiments need to be performed to optimize the parameters such as substrate feeding rate, resin loading and enzyme concentration inside the reactor. 
6.6.2 TA system In order to be able to compare the performance of the IMMPBR system with the batch system, reactions were performed with the same enzyme loading (g of enzyme/L of total system volume). Two experiments were run in IMMPBR, WC1 and WC2, varying the substrate flow rate, recycling rate and resin loading as shown in Table 6.1. The E/S ratio varies accordingly depending on the substrate flow rate. The aqueous solubility of BA is estimated to be 1.63 g/L [181]. As such, batch experiments were run with substrate concentrations below the  aqueous solubility limit to avoid formation of a multi-phase system. However, for the IMMPBR system, since substrate will be added in fed-batch, it is attempted to use 2 different flow rates (high and low) in order to evaluate the performance with higher and lower concentrations. A lower recycling rate (1.0 µL/min) was employed for the lower substrate feed flow rate (1.5 µL/hr) in order to increase the residence time. Further, the resin loading was also varied to check for the effect of resin loading on the reaction performance. Initially, a hydrophobic PES membrane was used which showed reduced separation efficiency, deformation and fouling (Pictures of the membrane deformation can be found in Appendix 3b). However the hydrophobic PTFE membrane showed excellent stability and separation efficiency. This can be attributed to the higher permeability (bigger pore size) of the PTFE membranes and less physical interaction of the membrane material with the substrate. Using the IMMPBR, much higher biocatalyst yields, product concentrations and volumetric productivities were achieved compared to the batch system (Fig 6.7 a,c,d). However the biocatalyst yield in batch corresponds to single use of the biocatalyst, and does not take into account the recycling of the cells. The substrate yield (Fig 6.7 b) decreased drastically as compared to the batch system and this can be attributed to the fact that the selected resins are not selective enough towards the product as substrate was also recovered from the resins. Thus similar to the MAO system, the challenge is reduced to screening of various resins under operational conditions for selective removal of the product and not the substrate. 
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a)               b)           
    c)                  d)      Fig 6.7: Comparing the IMMPBR performance with the batch process for the process metrics: a) Biocatalyst yield; b) Substrate yield; c) Product concentration; and d) STY For WC1, the product concentration increased by more than 6 times to 7.9 g/L and the volumetric productivity increases by more than 4 times which are important parameters in view of achieving economic viability of the process. For WC2, the product concentration increased by 4 times while the volumetric productivity increased by more than 3 times as compared to batch. Comparing WC1 and WC2, more product was produced in WC1, but higher substrate utilization was achieved in WC2. About 3.9 times higher amount of substrate was supplied in WC1 compared to WC2 while only 1.6 times higher amount of product was formed. This can be understood as for higher feed flow rates, a higher amount of substrate is adsorbed into the resin phase as the resins are not selective enough towards the product. The enzyme used to substrate converted ratio (E/S) was calculated to be 6.74 for 
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the batch, 0.223 for WC1 and 0.438 for WC2. Thus for the batch system the E/S ratio is much higher (15 and 30 times higher, respectively) as compared to that of the microsystem.  By supplying less substrate, at a lower flow rate, (comparing WC1 and WC2) and giving a longer residence time (lower recycling rate), the substrate utilization can be increased. However the amount of product produced was less, thus decreasing the volumetric productivity. Different strategies can be employed as to feeding the substrate first for a specific time and then re-circulating it for longer time in order to increase the substrate yield. However, if this strategy is supposed to work, it requires that the resins should have no sorption affinity towards the substrate. A smaller biocatalyst yield as compared with WC1 shows that the enzyme was less efficiently utilized. Thus it can be anticipated that the optimum is somewhere in between. Thus, it can be concluded that more knowledge about process operational windows can be gained from such experiments. 
a)   b)  c)  Fig 6.8: Evaluating the performance achieved in IMMPBR using CFE or WC for process metrics a) Substrate yield b) STY c) Product concentration Further experiments were performed to investigate the effect of the enzyme variant using CFE and WC’s. Such experiments would help in understanding the enzyme stability and activity over a period of time under operational conditions. Using WCs, because of the presence of the cellular membrane, the enzyme is not directly exposed to the reaction mixture, and the stability of the enzymes should be better compared to CFE. However, other issues such as the mass transfer from the aqueous phase into the cell through the cell membrane, and furthermore the mass transfer from the cell to the aqueous phase have an impact on the reaction rate. Higher substrate utilization, product concentration and volumetric productivity were achieved using whole cells (Fig 6.8 a, b, c). This can be attributed to the 
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stability of the enzyme in the WC form over longer periods of operation, and might indicate that the mass transfer through the cell membrane is not the bottleneck.  
6.6.3 Process parameter optimization studies: The workability and the performance of the IMMPBR system was demonstrated in the previous results (6.6.1) which demonstrated that below inhibitory level concentrations for substrate and product inside the reactor can be obtained. Also, the system was tested for the stability and activity of the enzyme form to be used under operational conditions (6.6.2). Further, such miniaturized set-ups can also be used for process parameter optimization studies, which will give an improved understanding on the sensitivity of the process to the different process conditions. However, only three parameters are tested here to check for the performance: substrate feed flow rate (µL/hr), resin loading (g/L) and recycling rate (ml/hr). These three parameters have direct influence on the residence time and the dynamic reaction rates (concentrations of substrate and product inside the reactor). These parameters are varied for the experiments as shown in Table 6.1. 
a)  b)  Fig 6.9 Aqueous concentration in the reactor module of: a) Substrate; b) Product The inhibition profiles for the enzyme [181] show considerable loss in enzyme activity at product concentrations above 0.2 g/L and substrate concentrations above 1.49 g/L. Thus it is intended to have below inhibitory level concentrations inside the reactor at steady state to ensure high enzyme activity. Thus at the end point, the concentrations inside the reactor are analyzed (Fig 6.9) (assuming the system is at steady state when the end point measurement is taken). The results show that with the present set of conditions this cannot be achieved. Inhibitory levels are marked with dashed lines in Fig 6.9. This can be attributed to the selectivity of the resins and the lower partition coefficient of the product between the solid phase and the aqueous phase.  
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a)     b)   
c)  d) Fig 6.10: Optimization of IMMPBR performance and evaluating with process metrics: a) Product concentration; b) STY; c) Substrate utilization; and d) Biocatalyst utilization  Experiment CFE2 was performed with a higher resin loading of 100 g/L, where higher product concentrations and volumetric productivities can be obtained (Fig 6.10 a, b) while having a better biocatalyst yield and substrate yield. Further experiments (CFE3 and CFE4) were performed with lower substrate feed flow rate, but less product was produced while the aqueous substrate and product concentration inside the reactor were increased (Fig 6.9 a, b). This can be attributed to the higher recycling rate and thus shorter residence times inside the reactor. Thus, another experiment (CFE5) was performed with lower recycling rate which resulted in lower concentrations of substrate and product inside the reactor (Fig 6.9 a, b). Thus it can be concluded that better results can be obtained with higher resin loading, lower recycling rates and higher substrate flow rates.  But further 
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optimization experiments need to be performed to verify the performance of the system. These studies help us in understanding the operational windows for different operational parameters.  
 Fig 6.11: Multifunctional screening using metrics for biocatalyst utilization and product concentration Since the solubility of the substrate is about 1.63 g/L, it can be seen that for all the experiments (Fig 6.9) the substrate concentration inside the reactor was above solubility limits indicating the presence of a 2-phase system inside the reactor. However for experiment CFE5, the experiment with the lower substrate flow rate and lower recycling rates, concentrations closer to the inhibitory and the solubility concentrations could be achieved inside the reactor. This was also confirmed using WC2, where with lower recycling rates below inhibitory level concentrations inside the reactor were achieved. This can be attributed to the longer residence times inside the reactor and the packed column. However as described before, these results are influenced by the fact that it is an endpoint measurement, which gives less insight into the dynamics of product formation. But further experiments can be performed for different operational times because of the ease of conducting experiments at this stage. Another major advantage of performing experiments with an integrated microsystem is the ability to perform multifunctional screening (Fig 6.11). If the product concentration and biocatalyst yield are considered as the two important design metrics, then it can be seen from Fig 6.11 that scenario CFE3 has better metrics as compared to CFE2 when only product concentration is considered as the process metric. As described in section 4.2.1, another powerful tool is the windows of operation technique to identify the feasibility or operational windows for various operational parameters. Based on the threshold values defined in [45] (relaxed for the difficult reaction using TA), the process performance is evaluated, and that can be achieved using the present set-up with IMMPBR (Fig 6.12). The results show no overlap or feasibility window. This indicates that with the three optimization parameters 
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considered here, economical viability of the process for industrial scale production cannot be achieved. Thus there is a need for further improvement of the process which can either be improvement of the biocatalyst or selecting a resin with higher selectivity towards the product. 
 Fig 6.12: Windows of operation. In the lower left-hand corner the experimental results are grouped together, while the upper right-hand corner is the region that is to be targeted in order to achieve an economically viable process Further comparing CFE1 and CFE2, it can be observed that by just increasing the resin loading higher product concentrations, volumetric productivities, substrate and biocatalyst yields can be achieved. Thus the amount of resin needed for obtaining the required product concentrations and volumetric productivities can be estimated by extrapolation as shown in Fig 6.13. This can however be further confirmed with experiments.  
 Fig 6.13: Volumetric productivities that could be achieved using only resin loading as an optimization parameter (extrapolated) 
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6.7 Discussion and conclusion Today many of the promising biocatalytic reactions are neither well developed nor optimized. Furthermore the extensive research and continuous expansion of the enzyme libraries have provided engineered biocatalysts operating at a wide range of process conditions. This provides us with the next big challenge, and that is to identify the right biocatalyst, from the wide range that is available, with high productivity under operational conditions that are relevant to allow further process development. Since the process development lead times become so crucial for economical viability, it is important to reduce the lead times for selecting the biocatalyst and checking for process feasibilities. Many process alternatives which might be potential solutions need to be rapidly screened. There is a need to systematize the process development through modularity. This screening of process alternatives is required from the very early stages of biocatalyst development (through protein engineering) onwards to the final stages of process optimization and scale-up. Thus effective screening through customized modules at microscale has been demonstrated by selective case studies. Further optimization studies to effectively gain more process knowledge have also been demonstrated. Since process economic viability greatly depends on the process metrics such as volumetric productivity, there is a need for combining optimization of processes while screening for process alternatives in order to identify the winning combination. Screening for economic viability includes optimization of for instance, enzyme concentrations, substrate concentrations and product titer values. Fast screening of process alternatives stands as the bottleneck because if the biocatalyst does not meet the criterion, the next best needs to be screened.  For the MAO system, it is shown that the application of process techniques, ISPR and ISSS, resulted in an enormously improved performance achieving below inhibitory level substrate and product concentrations inside the reactor. Comparing the amount of enzyme used for IMMPBR experiments with the batch experiments, 7 times more experiments can be performed with the same amount of enzyme. Assuming a final biomass concentration of about 50 g CDW/L during fermentation in a 100 ml conical flask (cell culture at lab scale), about 5 g CDW of biocatalyst can be obtained. Assuming 20 ml of operating volume at batch scale and 3 ml at IMMPBR scale (including process techniques), starting from 100 ml cell culture, 5 biocatalysis experiments can be performed for each fermentation at batch scale while the IMMPBR allows about 33 experiments to be performed. The latter can potentially lead to a drastic reduction of the process development lead times, since more parallel experiments can be performed starting from the same culture. However because of the constraints, lower expression of the enzyme [224] in the cells and selectivity of resins, the economic viability of the process to industrial scale could not be achieved (based on the predefined process metrics). 
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For the TA system, it is shown that the application of process techniques resulted in a greatly improved performance compared to batch scale. However, the concentrations - measured as the end point measurement - for the substrate and product were higher than the inhibitory levels meaning that the enzyme was not operating at its highest reaction rate. Further, the results also confirmed that for the chosen operational time of 37 hrs, the WCs were better compared to CFE owing to the higher stability of the enzyme in the WC form. Some operational parameters were optimized in order to test the system for economic viability but the required threshold values of predefined process metrics could not be achieved. Thus, a better enzyme variant is needed or product selective resins are needed in order to increase the economic viability.  The state of the art for transaminase catalyzed reactions has been reported by Tufvesson and co-workers [103]. The data shows the wide applicability of transaminases for the production of different chiral amines. The performance achieved through using CFE or WC in an IMMPBR system is comparable to the ones reported in the literature where experiments were performed at larger scales (lab scale). This shows that the capability and the applicability of using the IMMPBR for performing process development is comparable to the larger systems. However, only two of the reported processes [103] meet the requirements for the specified metrics [45] which are the synthesis of Sitagliptin [40] and αMBA [234] using free enzyme and free enzymes in a cascade system respectively.  Identifying resins with increased selectivity towards the product will also further ease the downstream processing. Downstream processing is another big challenge when substrates and products are similar in their properties for instance for the TA catalysed reaction where the ketone substrate and the amine product have similar hydrophobicity, net charge, and volatilities. The molecular weights of the species are also quite similar since only an amine group is transferred from the substrate to the product. This creates a major challenge to purify the product and also in selecting the best ISPR method. Using synthetic resins that are highly selective towards the product would ease the isolation of the product and downstream processing, but it is hard to achieve the required selectivity when both the substrate and product have similar logP values and net charge (at operational pH value). LogP values were estimated for MPPA and BA to be 2.12 and 1.96 which shows that separation by hydrophobicity is hard to achieve. So the next best option is to use separation by charge. The subsequent logical step would be to use ion exchange resins for product isolation, and to test for the efficiency of these at operational conditions. In order to increase the enzyme stability and biocatalyst yield over long periods of operational time, industrial processes use immobilization as the solution to recycling and reuse of the biocatalyst but this adds up even more to the cost of the production processes. In general, the use of the crudest form 
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of the enzyme, whole cell or cell free extract, is most economical but only if it doesn’t compromise with the process metrics. For enzymes requiring expensive co-factors, in situ cofactor regeneration using whole cells is most economical. Thus, as the bottlenecks for every biocatalytic reaction change, modularity becomes crucial during process development. Further using microsystems for fermentation (biocatalyst production), biocatalysis and product isolation can be integrated into one continuous process, i.e., a miniplant. Such systems can then be used as effective screening tools starting from fermentation to product separation and the whole process can be screened in one continuous operation. Novel techniques to speed up the process development indeed have to be identified for the biocatalytic processes to sustain in the industry.     
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7 Scale-up and process design 
This chapter deals with developing a screening methodology for process development which would further help in scale-up and process design. Limitations to the applicability of the proposed methodology will also be discussed.  
7.1 Process development using microstructured devices Systematic approaches to process development of biocatalytic reactions have been addressed by researchers as discussed before where it is desired that the biocatalyst development and process development must go hand-in-hand to address the process limitations. However not many have addressed the concepts of screening for process intensification and optimization during process development. Using microstructured reactors, data can be collected relatively fast using smaller amounts of expensive biocatalysts while also a characterization of the process intensification can be achieved.  A systematic screening methodology to process development using microstructured devices is proposed here (Fig 7.1). The procedure starts with the determination of target values of the desired process metrics (substrate yield, biocatalyst yield, product concentrations, space-time yield, amount of product etc) for the reaction system based on the economic evaluations (raw materials and product costs, manufacturing costs etc). The initial target values for the process metrics vary accordingly to the industrial sectors (bulk chemicals, fine chemicals and pharmaceuticals). The next step is to identify the limitations arising from the reaction (thermodynamics, pH, temperature etc), limitations to the biocatalyst (stability, toxicity etc) and limitations to the process (substrate and product inhibitions, solubility etc). Further, traditional strategies of process engineers, such as to use excess substrate/donor concentrations to shift the thermodynamic equilibrium and increase the yield, should also be explored here. These experiments can be conducted using multi-well plates as hundreds of experiments can be performed relatively fast and limitations can be identified. These experiments form the basis for future process intensification strategies and screening. For instance, if substrate solubility is the limiting factor, then process techniques will focus on increasing the substrate availability. However if it is identified that the substrate inhibition to the biocatalyst (below solubility levels) is the limiting factor, then process techniques will focus on decreasing the substrate concentrations (to below inhibitory levels) in the vicinity of the biocatalyst. Customized continuous flow reactor configurations can be developed based on the identified process limitations. 
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Fig 7.1 Biocatalytic process development – proposed screening methodology 
Scale-up and process design 
99  
Modular integrated microsystems can be developed by combining various process techniques to screen for the intensification achieved and for process optimization studies. However the application of each process technique has a cost factor associated with it. As such the production costs of implementing process techniques (such as ISPR) needs to be evaluated. This may further lead to redefining of the process metrics to include the implementation costs. Promising solutions can be further optimized and tested for their economic viability. The enzyme form has significant impact on the process limitations and further targets. Screening for the enzyme form should be included both at initial batch scale studies for identifying the limitations and also during the later screening studies of applying process techniques. This is important as the stability and activity of the enzyme depends on its form, environment and operational conditions. For instance, as observed in chapter 6, for the TA system (Fig 6.2), the process performance using WC was better compared to using the CFE over operational time and after application of process techniques. Immobilization of the enzyme is a labour and cost intensive technique for initial screening purposes. However if the stability of the biocatalyst over operational time is identified as the major bottleneck, then immobilization techniques have to be explored and characterized. There is commercial interest with many companies (Purolite, C-Lecta, Codexis) focusing on immobilization, but relatively fewer industrial processes are developed using immobilized enzymes [235]. This can probably be attributed to the cost effectiveness of operation, with increase in stability and the loss in activity due to immobilization need to be evaluated.  Although the proposed methodology can be applied to many biocatalytic processes, there are limitations to the applicability. For instance the proposed methodology does not include the concept of multi-enzyme systems (cascade systems etc) which are also gaining popularity in industry. Also the proposed methodology does not include co-factor availability or optimization which can also be a major bottleneck in biocatalytic process development. Further the proposed nature of process development is particularly disadvantageous for industries requiring generic approaches or solutions (such as developing processes for multi-product production plants). Since the proposed solution is specific to the biocatalytic reaction system, it cannot be generalized to include other biocatalytic reactions using the same reactors or process techniques. However the proposed methodology is specifically advantageous for next generation biocatalytic processes, where improvements in the process convey significant economic returns and ensure sustainability.    
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7.2 Scale-up  The scale-up of biotechnological processes is one of the most challenging tasks in bioprocess development. This becomes much more challenging for pharmaceutical products as compared to fine or bulk chemicals because of the additional regulatory requirements. Traditionally, the bioprocess industries have addressed scale-up through dimensional analysis (maintaining the same dimensionless numbers across scales for instance for fermentation processes maintaining the same power numbers etc). Tufvesson and co-workers have identified some extra considerations required at scale (need for GRAS solvents, impurity profile of process feeds, pH control, addition of substrates, logistics/process timing) and constraints of scale (area/volume reduced heat transfer, pressure drop in packed beds, mixing time in stirred tanks, risk of contamination, power/unit volume of mixing) for biocatalytic processes [236]. They have stressed that successful scale-up of a biocatalytic process requires good understanding of the interactions between the biocatalyst and the chemical and physical environment inside the reactor. Thus it is important to replicate the physical and chemical environments for the biocatalyst across scales to be able to replicate the process performance. However biocatalytic processes are more complex for instance as enzyme stability, mixing intensity etc., vary across scales. The decrease in productivity through these process variations across scales is inevitable and needs to be addressed effectively. Scale-up using microreactors is often addressed by parallelization of multiple reactors. Thus the process intensification achieved during process development can be sustained to the full scale process. Gasparini and co-workers have demonstrated the concept of scale-up in flow by parallelization using Coflore agitated tube reactors (ATR) [237]. Compared to batch processing conditions, the system configuration resulted in efficient scale-up with reduction in reaction time, enzyme consumption and pressure drop for biocatalytic resolution of DL-alanine. However, developing customized reaction modules at microscale mimicking industrial scale reactors can also be useful for gaining process knowledge and intensification which can be used later on for direct scale-up. Although it is hard to mimic the selectivity attained at microscale, optimization of process conditions carried out at microscale can be effectively used for reducing the number of process alternatives in a full scale model.  As discussed in chapter 6, modular experimental set-ups mimicking pilot and industrial scales can be built at microscale, but it is then also important to ensure that relevant information can be obtained from these set-ups. For instance, if the stability or the inactivation of the enzyme over time needs to be tested, the experimental set-up can consist of substrate supply and product removal modules to ensure concentrations below inhibition levels. Then inactivity of the enzyme over time at relevant 
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process conditions can be tested by taking samples over a period of time. Since microsystems enable continuous operation (automated by pumps) such experiments can be performed relatively easily.   Lima-Ramos and co-workers [117] have pointed out that the product concentration is a particularly challenging process metric when scaling-up from laboratory to industrial scale. Thus, they have suggested the importance of mass scale-up at low volume operating conditions i.e., intensification at microscale. Volume scale-up can then be addressed while maintaining the intensification achieved at microscale. The optimal solution achieved at microscale can be replicated at macroscale by addressing only the constraints at scale (area/volume reduced heat transfer, pressure drop in packed beds, mixing time in stirred tanks, risk of contamination, power/unit volume of mixing). The initial process development requires time and resources to achieve the mass scale-up using the proposed methodology (Fig 7.1). However, the overall process development time and costs will be reduced due to the lower number of experiments that need to be performed at larger scale (volume scale-up). Thus, it is expected that the overall development costs and time before the pilot plant implementation will be reduced.  
7.3 Process design  Process intensification confronts many industries with radical changes to the current technology with respect to equipment and process design. There have been many barriers to its implementation although PI can bring significant benefits to efficiency, productivity, quality, safety, wastes and operating expenses,. Some of these are the large investments that need to be made, the lack of experience, financial risks etc. However PI is needed to ensure the sustainability of the process. As such new demonstration pilot plants were developed by a number of researchers for chemical processes before implementation on industrial scale [238]. Modular plant concepts have been developed, with modular microreactors as a “flow miniplant”, in EU FP7 project CoPRIDE [239]. The concept of using a flow miniplant was demonstrated by a continuous process of the epoxidation of soyabean oil using a mineral acid as catalyst which has been scaled to pilot scale production of 10 kg/hr [240]. Furthermore, other EU projects such as F3 FACTORY are dedicated to developing faster and flexible production factories using microreactors. Similarly Evonik industries have introduced the compact container-platform plant, Evotrainer, under the concept of future factories. Evotrainer is thus designed as a multifunctional and all-purpose plant platform using micro- and milliliter production apparatus covering the whole manufacturing process and plant including storage, reaction and purification modules. The concept is thus ideally suited for PI and scale-up studies. 
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Process design can be developed after understanding the basic constraints and properties of the process. Some of the process properties that guide the process design are highlighted here. Biocatalyst formulation can be identified as an important process property as this determines the unit operations required for developing process flow sheets. Using WC for biocatalysis, the process flow-sheet can include the filtration unit after the fermentation and recovery steps to isolate/re-suspend the biocatalyst before further use in the biocatalysis step itself. Mass transfer across the cell membranes for the substrate and product can also be a limitation using WC’s. Thus, unit operations for permeabilization of the cell membrane may be included in the process design. If it is intended to use isolated enzymes, then unit operations for cell disruption and protein isolation need to be included before the biocatalysis step. Furthermore, the type of reactor used for biocatalysis can be identified as another important process property. Reactor configurations can include traditional stirred tank reactor (STR), continuous stirred tank reactor (CSTR), fed-batch stirred tank reactor, packed bed reactor (using immobilized enzymes), fluidized bed reactor, bubble column reactor (for reactions using oxygen), membrane reactor (as discussed in chapter 6) or a novel reactor configuration (as discussed in chapter 3). The operational mode, batch, continuous or fed-batch mode, is another important property which influences the process flow-sheet (inclusion of pumps, reservoirs etc). Purification or downstream processing steps would depend on another process property or metric such as product concentration, the presence of impurities and the use of ISPR method (if used) etc. Many of the successfully implemented industrial biocatalytic process are a result of case-by-case studies. Thus the process design of biocatalytic processes is until now a case-by-case undertaking based on process properties.    
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8 Conclusions and future perspectives 
8.1 Discussion Biocatalytic processes are emerging as environmentally benign processes and potential replacements to conventional chemical production routes. In spite of these advantages, cost effectiveness of competing routes to the same product determines the sustainability of the process. Thus the success of biocatalytic processes is determined by their performance in comparison to the competing technologies. With the improvements in protein engineering, the biocatalysts can presently be engineered to operate under extreme conditions thus increasing the competitiveness. However the successful implementation can, in my opinion, only be tackled by a joint effort with improvements in the biocatalyst and process engineering. Thus process engineering strategies will contribute to ensure the competitiveness and sustainability in the industry.  At present, industrial process development is mainly carried out in existing or traditional reactors. Traditional reactors might therefore not be optimal for complex processes such as processes involving biocatalysis steps, since many parameters including the biocatalyst form, stability, activity, substrate and product intolerances, solubilities, temperature, pH and cofactors (regeneration, stability etc) must be considered. Because of this enormous complexity, the identification of optimal process and reactor configurations becomes extremely difficult. Further protein engineering techniques, such as directed evolution, random and site-directed mutagenesis, have generated many libraries of enzymes to screen and characterize. At present in many industrial process development projects screening and characterization is done at batch scale using multi-well plates, since hundreds of experiments can be conducted rapidly. However, because of the complexity of the biocatalysis, some enzyme variants or formulation which might prove to be better at batch scale experiments may not sustain for longer operational times or process conditions and vice versa some variants which might have sub-optimal performance at batch scale might perform well after applying process techniques. Thus it would be beneficial to have a modular screening tool that can incorporate various process engineering techniques for biocatalyst screening and characterization even during the early stages of process screening where the focus is most on reducing the library of potentially useful enzyme candidates in order to select the potential enzyme candidates. Further screening at operational conditions reduces the risk of decreased performance during scale-up. Thus a screening methodology is proposed for biocatalytic process development using microstructured devices. The proposed methodology intends to incorporate the importance of rapid and effective screening methods. By applying a methodological approach during early stage process development, the type of 
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information required for design and decision making is identified as well as targets for intensification can be identified. This enhances further the relationship between various disciplines, protein and process engineers, to work together in a multidisciplinary process development approach. For instance, Lima-Ramos has shown that lack of coordination between chemists and process engineers resulted in development of unfeasible process techniques, such as using excess amine donor (5-fold excess) to shift the thermodynamic equilibrium in transaminase catalysed reaction which worked well at bench scale but has proven to be unfeasible at large scale due to low aqueous solubility and high costs [46]. The methodology also aims to incorporate data interpretation and modelling tools to gain more process knowledge and understanding. Such information would further help with the development of optimal customized reactor configurations. The modular approach of the proposed methodology opens up the possibility of screening through integrating different process techniques and further process optimizations to investigate the economic feasibility even during early stage process development. Online analysis techniques could be quite beneficial to gain more process knowledge (product formation rate, kinetics etc). However, this was not included in this thesis. The online monitoring of the reactions should be the focus for future experiments, i.e., it should be investigated whether it is possible to develop suitable on-line measurements for the different compounds involved in the reaction.  
8.2 Conclusion The main goal of this thesis has been to explore the possibilities of using microstructured devices as tools for effective and rapid screening of process engineering options for selected biocatalytic reactions, and to develop customized solutions at microscale. The thesis focused on relevant case studies: ω-transaminase catalysed reactions which is one of the most acclaimed reactions in the past decade to achieving asymmetrical synthesised chiral amines and monoamine oxidase catalysed reaction which has shown promising results in industrial applications such as the production of the commercial drug telaprevir (Merck). The main challenges associated with process development have been highlighted. Over the past decade the use of microstructured reactors has contributed to the intensification of process development and the applications in various biocatalytic processes have been highlighted.   
Case study 1: The reaction scheme for this case study is the synthesis of MBA using ω-transaminase catalysed conversion of acetophenone using isopropyl amine (IPA) as the amine donor while generating the co-product acetone. The enzyme uses PLP as a cofactor to transfer the amino group from the donor to acceptor molecule. The kinetics of this reaction (ping-ping bi-bi mechanism) has been explored by researchers which shows substrate and product inhibitions. Also the 
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thermodynamic equilibrium was calculated to be favouring the substrate. Thus it requires significant process engineering strategies to improve the yield for economic viability. Customized microstructured configurations were developed and tested to gain more process knowledge and also for intensifying the process accordingly. A Y-junction inlet and outlet straight channel microreactor was fabricated and used for residence time distribution experiments and the diffusion coefficients of the substrate and product were approximated by comparing the acquired data with CFD simulations. This information was used to design and fabricate a new reactor configuration with 8-laminar parallel streams. The custom designed reactor configuration showed considerable improvement compared with a batch scale set-up. However because of the unfavourable thermodynamic equilibrium, slower reaction rates and restrictions to the length of the channel and residence times, higher substrate yields could not be achieved (maximum yield achieved was ~10%). Further optimization studies (varying the length, depth and type of the channels) can be explored to check for the performance. Additional process techniques need to be explored and applied to achieve economic viability of such difficult reaction using TA.  
Case study 2: The case study demonstrates the applicability of using microstructured devices and data interpretation tools such as CFD for screening synthetic resins and for design of a packed bed column for solid-phase extraction. Batch experiments were used for initial screening of the resins for reducing the number of potential candidates and to calculate the sorption isotherms and subsequently the distribution coefficient between the solid phase and the aqueous phase (by retrofitting the data to external isotherm models). A micro-scale packed bed column was used to screen the resin performance (dynamic loading and breakthrough curves) for different operational conditions (flow rates). Furthermore an integrated CFD model (including the hydrodynamics, mass transfer model and the sorption isotherm model) was used to obtain an approximation of the permeability and the pore and surface diffusivities and test the sensitivity of parameters. The integrated CFD model can be used to design the packed bed column also for other applications such as liquid flow through a packed column with immobilized enzymes. 
Case study 3: This case study deals with the synthesis of an industrially relevant imine product using monoamine oxidase. Initial experiments at batch scale were performed by a colleague [224] who showed the inhibitions to the enzyme activity at substrate concentrations above 14 g/L and product concentrations  above 0.15 g/L. Thus a modular integrated microsystem process was developed with fed-batch substrate supply and in-situ product removal using synthetic resins. The integrated microsystem showed effective substrate supply and product removal with concentrations well below inhibitory levels. Thus the microsystem has much better performance compared to batch scale 
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operation for the process metrics, biocatalyst yield, space-time yield and product concentration. However the substrate yield decreased as some of the substrate transported to the resin phase. Because of lower enzyme expression levels in the host cells and the lack of product selectivity of the resins, threshold values for the process metrics for economic viability could not be achieved. This demonstrates that a multidisciplinary process development approach is needed to increase the productivity by including the molecular biology techniques for increasing the protein expression levels and process engineering techniques of screening resins with higher selectivity towards the product.   
Case study 4: The overall reaction scheme for this case study is the synthesis of MPPA using the      
ω-transaminase catalyzed conversion of benzylacetone using isopropyl amine (IPA) as the amine donor while generating the co-product acetone. Initial experiments at batch scale were performed by a colleague [181] who showed inhibitions to the enzyme activity at product concentrations above 0.1 g/L. Further, the substrate has a low aqueous solubility of 1.6 g/L. Thus it is intended to operate the reactor below solubility concentrations of the substrate to avoid multi-phase systems. In order to achieve these goals a customized modular integrated microsystem process was developed including the fed-batch substrate supply and in-situ product removal using synthetic resins. The microsystem showed improved performance compared with the batch system for the chosen process metrics, but the substrate supply and product removal techniques were ineffective to attain below inhibitory level product concentrations to the enzyme activity. The microsystem showed better results using the whole cell formulation of the biocatalyst compared to the free enzyme (cell free extract) formulation. Further the results showed the ineffective substrate supply with the formation of a two phase system inside the reactor. Thus an optimization of process parameters, substrate feeding rate, recycling rate and the resin loading, was carried out. The optimization scenario achieved improved results for process metrics but the below solubility level substrate concentration and below inhibitory level product concentration could not be achieved. This implies that other optimization strategies such as increasing the enzyme to substrate ratio, a feeding strategy (varying the feed flow rates according to the concentration inside the reactor), further increase in resin loading etc., need to be performed to increase the productivities.  Thus the main conclusion of the thesis is that microstructured devices can be successfully used for screening the process intensification achieved during process development of biocatalytic reactions: optimizing the reactor configurations, engineering design of modules (eg. ISPR using synthetic resins), screening through modular integrated systems and further optimization of process parameters can all be realized in microstructured devices.  
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8.3 Future perspectives For effective and rapid biocatalytic process development, it would be desirable to test and compare the performance of all the options for process techniques listed in chapter 4 for ISSS, ISPR and biocatalyst stability (immobilization). Thus the next logical step would be to develop easy to handle plug and play modules for each technique such as using organic solvents or ionic liquids with and without membranes etc. Commercial kits of different process techniques are being developed by companies for effective screening. For instance, the companies Codexis and Purolite have jointly developed a screening kit with immobilized transaminases in a packed column format that can be used for direct screening of various reactions [241, 242]. Customized modules at microscale can be developed relatively easily and effectively and used for screening. This will save considerable time and money. For instance immobilization costs can be reduced significantly by performing experiments at microscale. Novel reactor configurations are also being developed by companies for biocatalytic reactions. For instance, Nordic Chemquest AB, Sweden has developed a novel reactor concept ‘SpinChem reactor’ (www.spinchem.com) for biocatalysis which consists of a rotating flow cell of catalyst bed while liquid flows through the cell. This configuration has been shown to perform better than the traditional stirred tank reactors and fixed bed reactors [243]. Such reactor configurations can also be developed at microscale so the development process would be cheaper. Further these novel reactor configurations need a lot of experimentation to gain more process knowledge (because of the lack of literature data) and before achieving the optimal solutions. Thus again micro-scale operations would save time and money, for example due to the reduced quantity of chemicals used per experiment.  In order to further explore the boundaries of microstructured devices for screening and optimizing biocatalytic processes, it would be beneficial to develop modules for upstream processes such as fermentation, cell lysis together with the reactor module and other modules for ISPR, downstream etc. In other words developing a complete mini-plant in flow to study biocatalytic process would be the next logical step. Further, improved on-line or in-line monitoring techniques are to be developed along with the complete mini-plant ideas. As discussed before, the concept of mini-plants has been explored for chemical reactions by many EU projects, but they can however also be extended to include biocatalytic processes without too much effort.   
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Appendix 1 
a) Adsorption/absorption of substrate (APH) to different materials used for tubing and sampling has been tested by inserting small pieces of different materials in 3 ml of APH (concentration of 1.33 mM) solution. Samples were collected after 24 hrs to check for the adsorption. 
 Fig 1a: Equilibrium tests of substrate 
b) 
 Fig 1b-1: Set-up showing the modular digital pump, the microscope and a microreactor 
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The pumps are initialized (using the commands) by resetting the plunger (piston) to zero position and set to fine resolution of 24000 steps. The required flow rate is calculated using the pump speed codes listed in Table 1a.  Table 1a: Pump speed codes 
1 466.67 0.04 1.12 416.67 0.05 1.23 366.67 0.06 1.44 316.67 0.07 1.65 266.67 0.08 1.96 216.67 0.1 2.37 183.33 0.11 2.78 166.67 0.13 39 150 0.14 3.310 133.33 0.16 3.811 116.67 0.18 4.312 100 0.21 513 8333 0.25 614 66.67 0.31 7.515 50 0.42 1016 33.33 0.63 1517 1667 1.25 3018 15.83 1.32 31.619 15 1.39 33.320 14.17 1.47 35.321 13.33 1.56 37.522 12.5 1.67 4023 11.67 1.79 42.924 10.83 1.92 46.225 10 2.08 5026 9.17 2.27 54.527 8.33 2.5 6028 7.5 2.78 66.729 6.67 3.13 7530 5.83 3.57 85.731 5 4.17 10032 4.17 5 12033 3.33 6.25 15034 2.5 8.33 20035 1.67 12.5 30036 1.5 13.89 333.337 1.33 15.63 37538 1.17 17.86 428.639 1 20.83 50040 0.83 25 600
Speed 
code µL/s/pump
Milliseconds for 
one time step
Seconds for 
full injection
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 Fig 1b-2: Example of a LabView code to achieve the flow rate for the specified time 
c) For the analysis of D-glucoses a commercial kit is used (EnzyPlus D-glucose / D-fructose from Biocontrol). The kit contains R1 (Buffer solution), R2 (ATP + NADP) and R3 (HK/G6PDH) units. D-glucose is phosphorylated by hexokinase (HK) when mixed with ATP, forming product glucose-6-phosphate. The enzyme glucose-6-phosphate dehydrogenase (G6PDH) reduces NADP to NADPH which can be measured at a wavelength of 340 nm. The concentration of NADPH corresponds to the amount of D-glucose which is calculated using a standard curve. The samples are diluted in order to get the concentration between 1 - 80 µg of D-glucose per 100 µL which is the linear region of the assay. 33.33 µL of R1, R2 and sample are added to 1000 µL of water in a cuvette. Pure water is used as the blank. The first absorbance measurement is taken after 5 minutes and used as the reference for the measurement. 3.33 µL of R3 is added and the absorbance is measured again when it reaches steady state. The difference in the absorbance is calculated and corrected with the blank.   
Watch time for command execution 
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d)  
 
 Fig 1c: Visual experiments and CFD simulations confirming the near laminar flow along the length of the channel  
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Appendix 2 
a) Surface areas can be found in Table 5.1. The weight of the resins was varied to obtain the same surface area. From the table below, based on the assumption of a constant surface area, C150 has 1.8 times higher loading as compared with AF5.  Table 2a: Amount adsorbed – constant surface area 
Resin 
Amount 
absorbed 
mmol/L 
Volume (ml) Weight (mg) 
Amount 
absorbed 
mmol/m2 AF5 42.261 1 15.1 0.00466457 C150 75.173 1 620.6 0.008353762  
b) The area under the curve is approximated using the TrapZ method in MatLab which is based on the trapezoidal numerical integration technique. ( , )Q trapz X Y=  returns the approximate integral of Ywith spacing increment X . For instance from the experimental data for the measured concentration at the outlet in a µ-PBR at a flow rate of 1 µL/s (Table 2b), Q  is calculated using the integral method to be 704.6776. The adsorbed area is the difference between the rectangular area and the area under the curve measured using the TrapZ method which is calculated to be 190.3224. This is used in equation 5.2 to calculate the amount adsorbed ( adsn ). Similarly adsn  is calculated for other flow rates.        
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 Table 2b: Experimental data – measured concentration at the outlet in µ-PBR at a feed flow rate of 1µL/s 
Real time (s) (X) Normalized concentration (Y)30 045 0.06021283560 0.10645383175 0.15987982890 0.225069678105 0.316302892120 0.379574329135 0.464400767150 0.521754081165 0.589513881180 0.637727585195 0.644641112210 0.702338292225 0.729630434255 0.755529011270 0.778803345285 0.800231657300 0.819669164315 0.840174467345 0.859430991360 0.860770261375 0.877674015390 0.877764506405 0.891754443420 0.904803272435 0.904948058465 0.927679444495 0.934068122555 0.936819054585 0.947243638660 0.960328664735 0.967025012780 0.973775654795 0.98532233810 0.98429073855 1   
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c) Experiments for adsorption and extraction of MBA using water were performed at two different flow rates (Fig 2c). Extraction was relatively faster than adsorption. 
 Fig 2c: Adsorption and extraction achieved at two different flow rates  
d) The governing equations for fluid flow in fluid and porous domains in Ansys CFX are defined by equations [1-13] 
Fluid domain For fluid flow, the governing equations [1-3] of mass and momentum were solved using the solver capabilities in Ansys CFX [211].  
Conservation of mass (continuity equation), ( ) 0U
t
ρ
ρ
∂
+∇ ⋅ =
∂
   [1] 
Conservation of momentum, ( ) ( ) MU U U p Stρ ρ τ∂ +∇ ⋅ ⊗ = −∇ +∇ ⋅ +∂    [2] where p is the static pressure, τ is the stress tensor, MS is the external source term which in the present case is zero. The stress tensor for Newtonian fluids is given by equation 3, 
2( )
3
TU U Uτ µ δ = ∇ + ∇ − ∇ ⋅ 
 
     [3] 
 Where µ is the molecular viscosity, the second term is the effect of volume dilation.  
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An additional variable AC  is defined as the concentration of the adsorbate (scalar) in the fluid phase. The general form of the transport equation (advection and diffusion) for a scalar is defined as:  
( ) ( ) ( )U D S
t ϕ ϕ
ρϕ
ρ ϕ ρ ϕ
∂
+∇ ⋅ = −∇ ⋅ ∇ +
∂
     [4] 
where U is the fluid velocity, ρ is the mixture density (mass per unit volume), φ is the conserved quantity per unit volume (concentration), φϕ ρ=  is the conserved quantity per unit mass, Sϕ is a volumetric source term (with units of conserved quantity per unit volume per unit time), Dϕ is the kinematic diffusivity for the scalar. 
Porous domain The resin particles are defined as a porous domain (full porous model) in CFX [24] and the fluid flow inside the pores is defined as laminar flow. The volume porosity,γ , at a point is the ratio of the volume 
V ′ available to the flow in an infinitesimally small control cell surrounding the point, and the physical volume V of the cell. Thus, 
V Vγ′ = ⋅        [5] 
The vector area available to the flow, A′  through an infinitesimally small planar control surface of vector area A is given by, 
A K A′ = ⋅        [6] 
where ( )ijK K= is a symmetric second rank tensor, called the area porosity tensor. CFX assumes K to be isotropic,  
ij ijK γ δ= ⋅        [7] 
The equations for conservation of mass and momentum are, 
( ) ( ) 0K U
t
γρ ρ∂ +∇ ⋅ ⋅ =
∂
      [8] 
( ) ( )( ) ( ) 23
T
e MU K U U K U U U S pt
γρ ρ µ δ γ γ
 ∂  +∇ ⋅ ⋅ ⊗ −∇ ⋅ ⋅ ∇ + ∇ − ∇ ⋅ = − ∇  ∂   
  [9] 
Appendix 2 
134  
where U is the true velocity, eµ is the effective viscosity, which in the present case is a laminar viscosity and MS is a momentum source Additional variables, AC  and AWC  are defined as concentrations of the adsorbate (scalar) in the fluid phase and the surface of the particle. The general scalar (additional variable) advection-diffusion equation in a porous medium is defined as, 
( ) ( ) ( )K U K S
t
γρϕ
ρ ϕ ϕ γ
∂
+∇ ⋅ ⋅ −∇ ⋅ Γ ⋅∇ =
∂
    [10] 
Equation 10 is used for the transport of AC  in the pores inside the resin particle whereas only the diffusive terms of the equation are used to define the diffusive transport of AWC on the pore surface of the resin. The values for kinematic diffusivities of the scalar in the bulk fluid, inside the pores and on the surface of the particle can be defined independently. The momentum loss inside the pores of the resin is defined by an isotropic loss model, assuming isotropic porosity inside the particles. The isotropic loss model, equations [11 - 13], is defined using permeability through the resin and a resistance loss coefficient. 
, 2M x x loss xperm
S U K U U
K
µ ρ
= − −      [11] 
, 2M y y loss yperm
S U K U U
K
µ ρ
= − −      [12] 
, 2M z z loss zperm
S U K U U
K
µ ρ
= − −      [13] 
Where , ,x y z represent the directions, MS is the source term to be incorporated into the general conservation of momentum equation 5, U  is the fluid velocity in the case of a fluid or porous domain,  
ρ is the mixture density (mass per unit volume), permK  is the permeability and lossK  is the quadratic loss coefficient. The linear component of this source represents viscous losses and the quadratic term represents inertial losses.      
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e) The permeability coefficient permK , governs the viscous losses and is given by the equation 
2 3 2 2[( )* ( )* ( )] / [150*(1 ) ]per p om D SK γ γ−=     [14] and the resistance loss coefficient governs the inertia effects and is given by the equation 
32 [175 (1 ) / ( ( )]lo pssK S Dγ γ∗ ∗ − ∗ ∗=      [15] The particle porosity value (γ ) can be obtained from Table 5.1. oS is the sphericity (= 1 for spheres), 
pD is the particle diameter.  
 
f) Experiments were performed in µ-PBR with loosely packed bed (resin loading of ~8 mg) at initial feed concentration 
0A
C of 49 mM of MBA and at flow rate of 1 µL/s.  
 Fig 2f: Normalized concentration
0A A
C C measured at the outlet of the µ-PBR 
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 Fig 3a-1: Schematic diagrams of the reactor module (bottom section and top lid)    
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          Fig 3a-2: Experimental set-up and details of the reactor module b)   
                 Fig 3b: PES membrane deformation after ~10 hrs and ~15hrs  of operation using TA system   
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